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Maintenance of adequate cerebral perfusion during normal physiological challenges requires 
integration between cerebral blood flow (CBF) and systemic blood pressure (BP) control 
mechanisms.  Previous studies have shown that cardiac baroreflex sensitivity (BRS) is inversely 
related to some measures of cerebral autoregulation (CA).  However, interactions between the 
sympathetic arterial baroreflex and cerebral perfusion control mechanisms have not been 
explored.  To determine the nature and magnitude of these interactions we measured R-R 
interval, blood pressure, cerebral blood flow velocity (CBFv) and muscle sympathetic nerve 
activity (MSNA) in 11 healthy young males.  Sympathetic BRS was estimated using modified 
Oxford method as the relationship between beat-to-beat diastolic blood pressure (DBP) and 
MSNA. Integrated CBF control was quantified using transfer function analysis (TFA) metrics 
derived during rest and Tieck’s autoregulatory index (ARI) following bilateral thigh cuff 
deflation. Sympathetic BRS during modified Oxford trials was inversely related to ARI (R = 
0.64, P = 0.03). Sympathetic BRS during spontaneous baseline was positively related to TFA 
gain (R = -0.74, P = 0.01). Resting integrated MSNA per 100 heartbeats was also inversely 
related to TFA Gain (R = 0.57, P = 0.06).  These findings indicate that males with attenuated 
CBF regulation have greater sympathetic BRS (and vice versa), consistent with compensatory 
interactions between blood pressure and cerebral perfusion control mechanisms. Such 
interactions may explain the physiological diversity inherent in functionally redundant systems 
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Chapter 1. Introduction  
Constant oxygen and nutrient delivery to the vital organs is essential for maintained cellular 
function and is a core function of the cardiovascular system. This is especially true for the brain, 
which while only contributing to 2% of total body mass, accounts for 20% of resting energy 
consumption [1]. Due to high metabolic demand, the brain is highly susceptible to ischemic 
injury. An occluded cerebral artery can cause a transient or permanent reduction in cerebral 
blood flow (CBF), resulting in an impaired ability to deliver essential substrates such as glucose 
and oxygen, ultimately impairing the energetics necessary for maintaining ionic gradients [2, 3]. 
Conversely, excessive perfusion can result in the breakdown of the blood brain barrier [4]. Strict 
regulation of cerebral perfusion via a relatively stable cerebral blood flow is therefore necessary 
to maintain adequate brain function.  
  
The maintenance of systemic blood pressure (BP) is key to ensuring adequate blood delivery 
throughout the body and requires the integration of multiple regulatory mechanisms that 
individually act over a broad range of time scales. The renal system regulates long term BP 
through altering total blood volume while the baroreflex operates on a shorter timescale altering 
heart rate and total peripheral resistance in response to acute BP perturbations. In addition to 
systemic BP regulation, vascular mechanisms such local coronary [5], renal and cerebral 
autoregulation (CA) [6-9] ensure that local blood flow is buffered in the face of systemic BP 
perturbations. Following Ohm’s law, regional blood flow is equal to change in pressure divided 
by resistance. Because resistance is inversely related to vessel radius to the fourth, small changes 
in vessel cross-sectional area can effectively offset large changes in blood pressure, maintaining 
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a constant local blood flow. Local resistance modulation ensures that each vital organ’s perfusion 
demand is met regardless of whether or not systemic blood pressure is adequate.  
  
Both BP regulation and local blood flow regulation mechanisms have been studied extensively in 
relation to cardiovascular disease risk. Decreased baroreflex sensitivity has been associated with 
greater negative outcome following cardiovascular episodes such as myocardial infarction [10] 
and intracerebral hemorrhage [11]. CA has also been observed in clinical scenarios, such as head 
injury [12]. Acute BP perturbations can be buffered both systemically by the baroreflex and 
through local resistance modulation via mechanisms such as CA. However, very few studies 
have demonstrated the relationship between systemic and local mechanisms and it remains a 
mystery how they interact to maintain homeostasis.  
  
Two studies recently demonstrated an inverse relationship between cardiac baroreflex sensitivity 
(BRS) and CA in healthy individuals, suggesting that individuals with an attenuated CA likely 
have a high BRS and vise versa [13, 14]. While these associations do not imply causation, they 
do provide a potential reason for the wide variability typically observed in flow-regulating 
mechanisms, and that between individuals, the two mechanisms may exist in a state of functional 
equilibria. However, these studies only account for the cardiac component of the baroreflex, 
which may not be representative of the sympathetic component of the baroreflex regulating 
arterial resistance [15]. Therefore, demonstrating the relationship between the vascular 
sympathetic arterial baroreflex and CA is necessary for a more comprehensive understanding of 
the integration between the two mechanisms.  
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Chapter 2. Literature Review  
2.1 End organ perfusion 
Compared to other tissues in the human body, the brain is relatively inflexible in terms of its 
need for extracting and consuming substrates from the blood. The brain’s primary means for 
generating ATP is through aerobic glycolysis for the break down of glucose into energy and CO2 
and requires a constant supply of glucose due to limited substrate storage [16]. Cerebral aerobic 
metabolism accounts for approximately 10-12% of total glucose use in adult humans [17-19]. 
Constant cerebral perfusion is necessary to meet the brain’s high metabolic demand. As a result, 
a diminished cerebral blood flow has the potential to incite a multitude of detrimental effects to 
cerebral tissue.  
 
Figure 2.1. CBF thresholds required for functional and morphological preservation of brain tissue. Reproduced from 
Heiss [20].  
 
The effects of prolonged cerebral ischemia have been well-documented following stroke or 
traumatic brain injury, demonstrating that cerebral neurons are highly sensitive and susceptible 
to irreversible damage [2, 21-23]. Both the severity and duration of a drop in cerebral blood flow 
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play a role in permanent ischaemic damage. A reduction in cerebral blood flow to 
25ml/100g/minute results in neuronal cell death in rodents [24] and in cases of focal ischemia in 
humans, a core area of hypoperfusion reduced to 15-18ml/100g/minute typically leads to 
necrotic cell death if not reperfused soon enough [25, 26]. The duration of ischaemia is an 
important factor as diminished cerebral blood flow not immediately severe enough to cause 
infarction can cause cell death if maintained for long enough (Figure 2.1) [27, 28]. Therefore, the 
ability to maintain adequate cerebral blood flow and quickly respond to ischaemic episodes is 
important for the maintenance of brain function. In normal healthy humans, the maintenance of 
cerebral blood flow occurs through the presence of a number of regulatory mechanisms acting 
both at systemic and local levels.  
  
2.2 Systemic Cardiovascular Regulation 
Systemic blood pressure regulation is an integrated process that is achieved through a number of 
different mechanisms. Renal control of blood volume, chemoreflex regulation of blood pH, and 
baroreflex control of cardiac and peripheral arterial properties all actively work to maintain 
blood pressure within a narrow range to maintain adequate perfusion under both dynamic and 
long-term perturbations.  The renal system ensures chronic mean arterial pressure (MAP) is 
maintained through blood volume regulation [29]. The chemoreflex alters ventilation and BP 
when arterial partial pressure of CO2 (PaCO2) or O2 (PaO2) is inadequate [30, 31]. The 
baroreflex alters heart properties and peripheral resistance in response to acute BP perturbations 
[32]. Together these systems work to ensure that systemic delivery of essential nutrients and O2 
and removal of waste products is maintained within acceptable physiological ranges. Though our 
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primary focus in regards to systemic cardiovascular regulation for this study is on the baroreflex, 
the roles of the renal system and chemoreflex must be acknowledged.  
 
2.2.1 Renal Blood Pressure Control 
The renal system contributes to BP regulation by altering blood volume in response to pressure 
changes. The close link between blood volume homeostasis and BP was first demonstrated in the 
early 1900’s by Earnest Starling, suggesting that fluid retention via the renal system is important 
to BP maintenance [33]. Later in the 1960’s, Guyton [34] and Borst and Borst-deGeus [35] 
demonstrated that regulation of arterial pressure occurs largely through renal sodium excretion. 
Though slower acting than other regulatory systems and mostly applicable to chronic BP 
changes, the renal system acts as a feedback loop and is the only system that has the ability to 
entirely correct arterial pressure back to its homeostatic level [29].  
 
The kidney regulates sodium and water balance through a process called pressure natriuresis. An 
increase in arterial blood pressure results in an increase in renal perfusion pressure, causing an 
increase in sodium and water excretion. The decrease in extracellular fluid volume leads to a 
decrease in BP [34, 36]. The renin-angiotensin-aldosterone system (RAAS) plays a key role in 
this process by altering the production of angiotensin II in response to changes in renal perfusion 
pressure. An increase in arterial blood pressure inhibits the RAAS axis, which decreases the 
systemic vasoconstrictor effect of angiotensin II on the afferent arterioles, decreasing solute 
reabsorption in the distal and proximal tubules. This process maintains a steady state between 
salt intake and excretion and angiotensin II levels, maintaining glomerular perfusion pressure 
and ultimately, MAP at around 100mmHg in normal healthy individuals.  
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Because of its ability return MAP to its desired set point, the renal system plays a crucial role in 
chronic BP maintenance. However, its maximum feedback gain takes much longer to respond to 
BP perturbations than other mechanisms and does not occur quickly enough to respond to 
dynamic BP perturbations. Therefore, other response mechanisms, such as the carotid baroreflex, 
are of greater importance for response to immediate BP perturbations.  
 
2.2.2 Chemoreflex 
Another factor affecting BP on a shorter time scale is the chemoreflex. The chemoreflex 
influences breathing rate and both cardiac and vascular control in response to changes in arterial 
PaCO2 and PaO2 [30, 31]. The underlying principle of the chemoreflex is to ensure that blood 
contains an adequate supply of O2 to meet the demand of aerobic metabolism occurring 
throughout the body. A decrease in PaO2 or increase in PaCO2 results in hyperventilation, 
increased heart rate and peripheral resistance to meet O2 demand via the chemoreflex. The 
peripheral and central afferent components of the chemoreflex play separate roles and are 
sensitive to different inputs. Though the underlying physiology of the chemoreflex is complex 
and the precise peripheral and central mechanisms are not entirely known [37-41], it plays an 
important role in ensuring that tissue O2 demand is met.  
 
The chemoreceptors are co-located the the baroreceptors peripherally in the carotid bodies and 
aortic arch and centrally at the brainstem and have detection and response characteristics unique 
to each location. The peripheral chemoreceptors respond primarily to hypoxia and to a small 
extent, hypercapnia and acidity [42], sending corresponding afferent signals through cranial 
nerves IX and X to the medulla. The central chemoreceptors on the other hand are predominantly 
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responsive to changes in PaCO2 and acidity [43] by detecting blood [H+]. Though the 
relationship between the peripheral and central chemoreceptors is still debated, a hyperadditive 
model has been proposed in which the gain of one can amplify the gain of the other [44]. 
Together, the two detect suboptimal blood gas levels and signal for physiological responses to 
return blood gas levels back to normal. 
 
The resulting effects of the chemoreflex are modulation of ventilation, heart rate and sympathetic 
nerve activity to the blood vessels [45-47]. An increase in ventilation increases circulating [O2] 
and decreases [CO2]. A rise in PaCO2 results in a linear increase in ventilation whereas a 
decrease in PaO2 results in nonlinear increase in ventilation, where lower levels are associated 
with a much greater ventilatory response. An increased PaCO2 or decreased PaO2 also results in 
an increase in nerve activity sent to the peripheral blood vessels to increase blood pressure, but 
this response is inhibited or buffered by thoracic afferents triggered by increased inspiration 
brought on through hyperventilation. A combination of increased PaCO2 and decreased PaO2 
potentiates the ventilatory response, and increase the sympathetic arterial response in the absence 
of hyperventilation [47].  
 
Unlike the baroreflex, the chemoreflex allows cardiovascular modulation in situations where 
circulating O2 and CO2 levels may be inadequate despite a normal blood pressure and flow. In 
this sense the chemoreflex plays a crucial role in perfusion maintenance where other mechanisms 
such as the baroreflex may not otherwise detect abnormalities. However, in situations where both 
the chemoreceptors and baroreceptors are activated, the baroreflex may override the autonomic 
and ventilatory responses of the chemoreflex [45, 48]. In normoxic normocapnic conditions, the 
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chemoreflex should not play a significant role in cardiovascular modulation and moment-to-
moment blood pressure modulation can be predominantly associated with the baroreflex. 
Therefore, in normoxic normocapnic conditions, it is generally assumed that the baroreflex 





Figure 2.2. Schematic representation of the cardiac and vascular components of the baroreflex. Arterial blood 
pressure perturbations are detected via the carotid and aortic baroreceptors and corresponding afferent signals are 
sent to the nucleus tractus solitaries (NTS) within the central nervous system (CNS).  This alters efferent signals sent 
to the heart and peripheral blood vessels, altering cardiac output and total peripheral resistance respectively, 
Buffering BP.  
 
The baroreflex plays a key role in the short-term regulation of BP. To maintain an adequate 
pressure gradient between the arterial and venous circulation, allowing continuous systemic 
blood circulation, the baroreflex regulates systemic BP through the control of both cardiac output 








relationship between HR and BP was first noted by Marey in 1863 [49] which lead to the 
speculation of a negative feedback system for BP maintenance and ultimately the concept of the 
baroreflex. The underlying concept of baroreflex feedback is that a change in BP is sensed by the 
baroreceptors and the central nervous system responds by altering both CO and systemic arterial 
resistance. Through changes in CO and arterial resistance, the barorefex is able to offset acute 
increases [50] or decreases [51, 52] in BP. With the development of the variable neck pressure 
chamber in 1957, Ernsting and Parry conducted the first of a series of experiments that 
demonstrate the role of the individual components of the baroreflex [53]. Through using the neck 
pressure chamber stimulus technique, they demonstrated that despite administering a vagal 
blockade atropine to block the efferent HR response to increased stretch of the baroreceptors, 
blood pressure remained depressed, suggesting that arterial resistance modulation still plays a 
role in BP maintenance in the absence of cardiac baroreflex [53]. This initial experiment was the 
first to indirectly demonstrate separate function of the cardiac and sympathetic arterial 
baroreflex. 
 
The baroreceptors detect vessel stretch in the carotid sinuses and aortic arch with changes in BP. 
Functioning as a mechanoreceptor, the baroreceptors detect vascular distention as opposed to 
blood pressure per se [54]. The baroreceptor afferents are relayed through the nucleus tractus 
solitarius (NTS). Based on this input (increased or decreased firing based on the stretch of the 
baroreceptors), the NTS sends signals to the nucleus ambiguus which controls vagal activity 
[55], and the rostral ventrolateral medulla which controls vasomotor activity [56]. Together, 
these two regulatory pathways provide an integrated response to attenuate BP perturbations and 
are modulated via two separate neural pathways.  
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The baroreflex has two primary effector arms – the sympathetic and parasympathetic nervous 
systems. Sympathetic neural signals are sent to both the heart and systemic vasculature while 
parasympathetic baroreflex signals are only sent to the heart. The sinoatrial (SA) node and 
atrium of the heart are densely innervated by sympathetic and parasympathetic nerve fibers [57, 
58]. An increase in sympathetic input to the heart results in an increased heart rate, contractility, 
conductivity and positive lusitropy (myocardial relaxation). Parasympathetic input via the vagus 
nerve decreases the firing rate of the SA node, counteracting the sympathetic cardiac component 
of the baroreflex [59, 60]. An increase in sympathetic activity to the systemic vasculature results 
in vasoconstriction and ultimately, an increase in total peripheral resistance.  
 
Together both the cardiac and sympathetic arterial functional divisions of the baroreflex work to 
buffer acute BP changes but they are often assessed separately [15]. Cardiac baroreflex 
sensitivity is quantified as the slope of the relationship between systolic blood pressure (SBP) 
and R-R interval while sympathetic arterial baroreflex sensitivity is quantified as the slope of the 
relationship between diastolic blood pressure (DBP) and muscle sympathetic nerve activity 
(MSNA). For both components, a steeper slope is associated with greater BRS. Although 
‘normal’ ranges for BRS have not been defined, it is generally thought that blunted sympathetic 
arterial or cardiac BRS are associated with poor outcome in a number of disease states. Low 
sympathetic arterial BRS has been associated with vasovagal syncope [61] and obstructive sleep 
apnoea [62]. Myocardial infarction patients with a cardiac BRS under a threshold of 3 ms 
mmHg-1 are suggested to be at greater risk of mortality over a 2-year follow up [63]. Attenuated 
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cardiac BRS has also been associated with coronary artery disease[64], hypertension[65] and 
chronic heart failure [66].  
 
2.3.1 Mechanoreceptor Sensory Input and Afferent signaling  
Changes in BP are detected by baroreceptor nerve endings. Baroreceptor nerves detect stretching 
of the vascular wall with changes in intraluminal pressure. Both absolute stretch and rate of 
stretch occurring with each pulse are detected, providing a graded electrical response sent to the 
central nervous system (CNS) via afferent fibers [67]. These nerves are spray-type 
mechanoreceptor nerve endings found in the carotid sinus of the internal carotid artery and aortic 
arch. Baroreceptors consist of both A- and C-fibre types and the distinction between the two is 
based on conduction velocity, myelination and threshold. A-fibres are fast conducting, large-
diameter myelinated fibres and are selectively activated at low-voltage stimulation (less than 5V, 
0.1 ms). C-fibres, which are more abundant, are smaller-diameter unmyelinated fibres that 
become activated at stimulations of 5 to 20V. The two fibre types demonstrate distinct frequency 
responses as well, with A-fibres requiring higher frequency input than C-fibres. This suggests 
that A-fibres provide a more dynamic response whereas C-fibres provide a steady-state response 
[68]. Arterial baroreceptor afferent fibers have also been classified as either type I or type II [69]. 
Type I fibers are larger caliber A fibers that have a high pressure threshold, in that they require a 
greater pressure change to elicit an afferent nerve signal. They discharge abruptly with an 
increase in pressure and are predominantly inactive at steady baseline pressures. Type II fibers 
are unmyelinated C fibers or smaller A fibers which are spontaneously active during steady 
baseline blood pressures and demonstrate continuous sigmoidal firing to an increase in pressure 
[69, 70].  
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Sensory information from the carotid baroreceptor nerve endings is carried via afferent fibers 
through the carotid sinus nerve and glossopharyngeal nerve to the medulla. Similarly, 
information from the aortic arch baroreceptors travels through the aortic depressor and vagus 
nerves to the medulla [67]. Both myelinated A fibers and unmyelinated C fibers are involved in 
the afferent signaling. The baroreceptor neurons have afferent terminals in the wall of a vessel 
and efferent fibers projecting into the CNS and are bipolar cells (having two extensions) [71]. 
Arterial baroafferents terminate predominantly rostral to the obex of the NTS [72, 73] whereas 
cardiac baroafferent fibers terminate within the medial subnucleus of the NTS[74]. 
 
The ability to detect and relay BP information is important for maintaining a stable BP. Early 
animal experiments using sinoaortic denervation in dogs demonstrated the importance of 
baroreflex afferent input for attenuating blood pressure variability (BPV). Though the subjects’ 
24-hour MAP remained the same, removal of baroreflex afferent nerves resulted in an increase in 
acute BP variability [75].  
 
2.3.2 Central Nervous System 
Cardiovascular and baroreflex integration occurs at the medullary cardiovascular center of the 
medulla oblongata beginning at the NTS. The NTS acts as the initial CNS processing center, 
receiving and redirecting afferent inputs from arterial baroreceptors and chemoreceptors as well 
as a variety of other afferent signals[71]. The rostral component of the nucleus is present on both 
sides of the medulla and meet at the level of the obex along the midline [76]. The NTS is made 
up of a heterogenius group of neurons, differing in neuronal input and output, neurotransmitter 
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characteristics and anatomical features. The NTS plays a heterogeneous key role in the 
integration of all afferent baro- and chemoreceptor signals and further relays the combined 
signals from the baroreceptors to other parts of the medulla oblongata to regulate 
parasympathetic and sympathetic signals sent to the heart and peripheral vasculature.  
 
Though many other outputs exist from the NTS, the most significant to the baroreflex are the 
projections to the caudal ventrolateral medulla (CVLM). The CVLM converts incoming 
excitatory signals from afferent baroreceptor signals to an inhibitory effect on sympathetic 
activity [76-80]. The CVLM is made up of a rostral group of GABAergic neurons which are 
activated by baroreceptor signals via the NTS as well as other neuronal groups not affiliated with 
baroreceptor signaling [81]. Neurons in the CVLM release GABA as a neurotransmitter [77] and 
are still tonically active and inhibitory in the absence of afferent baroreceptor signals [82, 83].  
 
The rostral ventrolateral medulla (RVLM) vasomotor neurons are located caudal to the posterior 
facial motor nucleus, rostral to the pre-Botzinger complex, and ventral to the nucleus ambiguus 
complex and Botzinger complex. Vasomotor neurons of the RVLM project directly to the spinal 
cord [84]. Over a century ago, early studies on the RVLM demonstrate a decrease BP with 
bilateral destruction of a component of the ventral medulla but not by destruction of a large 
dorsal component of the medulla oblongata [85]. Further studies have demonstrated 
corresponding BP alterations to stimulation [86, 87] and inhibition of the RVLM [88, 89]. Most 
RVLM vasomotor neurons demonstrate intrinsic pacemaker activity not depending on synaptic 
inputs [90-92]. As such, it is postulated that the neurons of the RVLM are responsible for 
generating resting sympathetic vasomotor tone. Most RVLM neurons are sympathoexcitatory, 
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providing a glutamatergic output to sympathetic prepreganglionic neurons. Stimulation of 




Figure 2.3. Schematic showing the conceptual relationships between BP and resulting sympathetic baroreflex nerve 
activity. At maintained normal BP, afferent and efferent tonic nerve activity is maintained. An increase in blood 
pressure results in an increase in afferent nerve activity and decrease in efferent nerve activity. A decrease in BP 
results in a decrease in afferent nerve activity and an increase in efferent nerve activity.  
 
2.3.4 Cardiac Baroreflex  
The cardiac baroreflex is influenced by both parasympathetic and sympathetic nerves and 
modulates heart properties to regulate cardiac output (CO). Sympathetic excitation elicits an 
increased SA node activity, atrioventricular (AV) node conduction, excitability of the His-
Purkinje system, systolic contraction force and positive lusitropy [93]. Sympathetic stimulation 
is mediated predominantly by norepinephrine acting via β1-adrenoreceptors and results in 
increased heart rate, lusitropy, conductivity and myocardial contractility [94, 95]. Conversely, 
parasympathetic activity via the cardiac ganglia cholinergic neurons travelling through the vagus 




Afferent Nerve Activity Efferent Cardiac Nerve Activity Efferent Arterial Nerve Activity
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SA node predominates over the sympathetic input [59]. The baroreflex is able to manipulate the 
balance between cardiac vagal and sympathetic inputs in order to alter CO in response to BP 
perturbations. 
 
The cardiac component of the baroreflex has been studied in detail, including information on the 
relative contribution of individual components of the reflex and differences in response to rising 
and falling BP. Some studies on the cardiac baroreflex provide greater detail by accounting for 
the mechanical and neural components of the baroreflex [95, 96] The mechanical component 
refers to the transduction of blood pressure into barosensory vessel stretch and the neural 
component refers to the transduction of barosensory vessel stretch into changes in heart rate [95]. 
Previous studies demonstrate hysteresis in the cardiac baroreflex, where HR response to rising 
BP are greater than to falling BP. This has been demonstrated through both the neck 
suction/pressure method [97] and the modified Oxford method (described in section 3.1.7.2) [98] 
and while this may be explained by viscoelastic properties of the barosensory vessels, it has been 
suggested to be due in part to differences in the neural component of the baroreflex [95, 99].  
 
2.3.5 Sympathetic Arterial Baroreflex  
The sympathetic arterial baroreflex regulates arterial total peripheral resistance (TPR) via 
efferent nerve signals from the CNS [100]. Efferent neural signals from the CNS to the 
vasculature was first observed by Karl-Erik Hagbarth and Ake Vallbo in the Department of 
Clinical Neurophysiology at University Hospital in Uppsala, Sweden, who were originally 
attempting to address the prevailing concepts of muscle motor control by recording from skeletal 
muscle spindles via microneurography [101, 102]. Though not their original intent, their 
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technique’s greatest impact was on the understanding of the sympathetic nervous system in 
humans. Since then, microneurography has primarily been used in the study of MSNA and to a 
lesser extent, skin sympathetic nerve activity (SSNA) [103]. The development of this technique 
has allowed for in-depth study of the efferent component of the sympathetic arterial baroreflex. 
Simultaneous recordings from two separate nerves indicate MSNA is parallel regardless of nerve 
recording site [104]. This suggests that even though different sympathetic effector nerves are 
controlled individually, uniform sympathetic drive is sent to the vascular beds of skeletal muscle 
at rest. Therefore, MSNA is used as a quantification of systemic vascular nerve activity. 
 
Sympathoexcitatory outflow from the RVLM travels through efferent sympathetic nerve fibres 
throughout the body and occurs as bursts [105, 106]. Barosensitive efferent neurons are primarily 
unmyelinated C-type fibres [103] and demonstrate continual burst activity (see figure 2.3) at rest 
[100, 107, 108] which varies from person to person. Resting MSNA for a given individual 
remains constant over time and is reproducible, even when testing sessions are several years 
apart [109]. Obese individuals demonstrate higher MSNA [110] and MSNA increases with age 
over the age of 60 [111, 112]. Though resting MSNA plays a role in BP maintenance, its resting 
value is not directly related to resting BP [113]. In young normotensive males, resting MSNA is 
inversely related to CO. The role of CO in BP maintenance may therefore explain at least in part 
why MSNA is not directly related to BP [114].  
 
The sympathetic arterial baroreflex modulates MSNA in the presence of BP perturbations, 
altering peripheral vascular resistance. Efferent muscle vasoconstrictor outflow is coupled to the 
arterial baroreceptors and demonstrates discharge behavior with a strong cardiac rhythmicity and 
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the firing probability increases with activities that unload the baroreceptors and decrease with 
activities that load the baroreceptors [115, 116]. Additionally, burst probability fluctuates with 




Together, the cardiac and sympathetic arterial components of the baroreflex are able to quickly 
modulate BP in the presence of acute perturbations. By altering both CO and TPR, the effects of 
the baroreflex can result in a substantial increase or decrease in BP within seconds. Without this 
ability, ordinary BP perturbations common in day-to-day life such as orthostatic hypotension 
would be debilitating.  
 
The relevance of both cardiac and sympathetic arterial BRS have been tested for a number of 
clinical scenarios. Myocardial infarction patients with a cardiac BRS of 3 ms mmHg-1 or lower 
have been shown to be at greater risk of subsequent mortality [63].  Other studies have 
demonstrated lower cardiac BRS values in patients with coronary artery disease [64], 
hypertension [65], chronic heart failure [66] and essential hypertension (hypertension without a 
clear cause) [121]. While it is postulated that a low BRS poses a greater risk of these acute 
conditions, there are currently no official definitions of normal BRS and BRS in itself may not 
be representative of overall cardiovascular protection against these disease states [95].  
 
In addition to its potential protective role against fatal disease states such as those listed above, 
the baroreflex has been studied in relation to conditions affecting the ability to maintain organ 
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blood flow in the face of normal day-to-day perturbations. In a normal healthy individual, the 
baroreflex should offset acute BP perturbations but that is not always the case for all individuals. 
Conditions such as orthostatic intolerance or syncope can cause symptoms ranging from 
lightheadedness to a loss of consciousness, caused by an inability to maintain cerebral blood 
flow [122]. Because these conditions are characterized by an inability to maintain cerebral blood 
flow in the presence of acute perturbations, it seems possible that baroreflex function plays a role 
in these conditions. 
 
Hypovolemia is a decrease in central blood volume, occurring during upright posture 
(orthostasis) as a result of blood pooling in the legs due to gravity or hemorrhage [123]. A 
diminished tolerance to hypovolemia can have critical implications, resulting in symptoms such 
as lightheadedness, postural instability or even loss of consciousness upon standing [124].  A 
number of studies have demonstrated that orthostatic intolerance is associated with a diminished 
cardiac BRS [125-131]. Although subjects having a low tolerance to central hypovolemia (via 
lower body negative pressure) demonstrate a diminished ability to increase MSNA-mediated 
vascular resistance [122, 130, 132, 133], resting sympathetic arterial BRS has been shown to be 
the same in both high and low tolerance subjects [123].  
 
Cardiac and sympathetic arterial BRS may also have clinical significance in relation to syncope 
in general and vasovagal syncope (VVS) in particular. VVS is a common problem, affecting 
20% of people in their lifetime [134]. It is defined as a global reduction in cerebral blood flow 
resulting in transient loss of neurological function [135] and is associated with an empty left 
ventricle, vagal stimulation of the heart and widespread sympathetic withdrawal [136-138]. 
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Common triggers for VVS include central stimuli such as emotion, postural stimuli such as 
moving into an upright posture and situational stimuli, such as in response to micturition [139-
141]. Though the underlying anatomical or physiological cause remains uncertain [141], VVS is 
associated with peripheral hemodynamic changes [142] and due to the nature of VVS involving 
vagal and peripheral effects on systemic BP control, a relationship with BRS seems plausible. 
However, the role of baroreflex function in VVS pathophysiology remains controversial [138, 
140, 143-150]. Various studies attempting to elucidate a predictive model of VVS through either 
cardiac or sympathetic arterial BRS remain inconclusive, with some reporting a decrease [143, 
146, 147] or increase [148, 149, 151] in BRS in patients experiencing VVS.  
 
The assessment of baroreflex function may provide valuable clinical information on 
cardiovascular function. But while baroreflex impairment has been associated with clinical 
conditions affecting CBF maintenance such as acute stroke [11, 152-154], BRS quantification 
does not depict cardiovascular reflex function in its entirety. This may explain the discrepancies 
observed in studies on baroreflex function in conditions such as hypovolemia or syncope.  
Therefore, a better understanding of the interaction with other reflex mechanisms contributing to 
CBF maintenance such as CA may be necessary to provide a better understanding of the 
underlying pathophysiology. 
 
2.4 Cerebral Autoregulation 
Along with the baroreflex, local blood flow buffering via CA is suggested to play a large role in 
the maintenance of cerebral perfusion [6, 155, 156]. CA is defined as the ability of the brain to 
maintain constant blood flow in the face of cerebral perfusion pressure perturbations [155-157]. 
	 20	
Modulation of CBF was observed as early as the 1930’s, with observations demonstrating the 
constriction of pial arterioles in response to an increase in BP [158]. Despite this, it was mostly 
postulated that CBF passively followed changes in BP and that CBF stability was directly related 
to systemic BP regulation up until around 1959 [157]. Though the precise mechanistic function 
of CA is still debated, technological advancements such as transcranial Doppler ultrasound 
(TCD) provide evidence suggesting the presence of a local regulatory mechanism buffering CBF 
in the presence of BP perturbations [6, 8, 159]. 
 
Figure 2.4. Illustration of Lassen et al.’s [157] traditional model of cerebral autoregulation. For the original graph, 
each data point was representative of an individual subject. As result, the curve is representative of a population but 
is often misinterpreted as an intra-individual relationship.  
 
The traditional model of CA suggests that CBF is maintained at a constant level over MAP 
















et al. [157] which pooled multiple subjects data from multiple studies to plot average BP against 
total brain blood flow. The resulting plot demonstrates a plateau where cerebral blood flow stays 
constant between BP’s of 50 to 150mmHg, suggesting the presence an autoregulatory 
mechanism. This concept was further endorsed in a review by Paulson et al. in 1990 [156]. 
However, Lassen’s paper plotted data from seven different studies including 11 different patient 
groups having various BP levels caused by a variety of pathology- or drug-induced states on a 
single graph [157]. Many of the subjects in Lassen’s paper were premedicated with drugs that are 
now known to affect CBF regulation [160].  An attempt to replicate Lassen’s findings with the 
exclusion of potentially problematic subject groups resulted in a 7% increase in cerebral blood 
flow with every 10mmHg increase in BP and 2-7% decrease in cerebral blood flow with every 
10 mmHg decrease in BP [161]. Therefore, this suggests that Lassen’s traditional model of CA is 
not representative of intra-individual relationships between BP and cerebral blood flow.  
 
With the advent of TCD for the quantification of cerebral blood flow velocity (CBFv) (discussed 
in detail in section 3.1.4) as a surrogate measure of CBF in 1965 [162], studies began addressing 
the intra-individual temporal relationships between BP and CBF [6, 8].  The early evaluations of 
CA using TCD were conducted under steady-state conditions in which CBFv measurements 
were taken at constant baseline BP and after stepwise manipulations of BP. If CBF changes 
significantly with an increase or decrease in BP, CA is said to be impaired and if CBF is 
maintained at or near it’s baseline level, it is said to be intact [155, 156]. While quantification of 
static CA does provide valuable information about the buffering capacity of the cerebral 
vasculature, it can be a time consuming and invasive process, using the Kety-Schmidt technique 
[163] or 133Xe measurements [164], both of which require chemical tracer infusions to conduct. 
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Additionally, static measurements are only able to evaluate the overall effect of autoregulation 
and they do not account for the time in which CBF changes in the presence of BP changes [159].  
 
Figure 2.5. Average response of blood pressure (ABP), cerebral blood flow (CBF) and cerebrovascular 
resistance(CVR) following thigh cuff deflation. Thigh cuff deflation occurred at time 0. Tracings are shown in 
normalized units relative to recordings prior to thigh cuff deflation. Reproduced from Aaslid et al., 1989 [6]. 
 
Contemporary studies of CA using high temporal resolution TCD and BP measurement 
techniques were able to demonstrate the concept of dynamic CA, which unlike traditional studies 
of steady-state static CA, accounts for the temporal relationship between CBF and BP. The 
introduction of TCD measurement allowed for frequency-domain based analysis which 
demonstrates the beat-to-beat relationship between CBF and BP. Temporal relationships between 
CBFv and BP following hypotension induced by thigh cuff deflation were first demonstrated by 
Aaslid et al. [6] (Figure 2.5). They found that CBFv decreased following the fall in MAP but 
returned back to its original value quicker than MAP. This was later confirmed in studies 
employing other methods of induced hyper- and hypotension, such as bolus drug injection of 
sodium nitroprusside (SNP) and phenylephrine (PE) [165, 166] or standing from sitting position 
	 23	
[167]. The observations countered traditional concepts of CA, suggesting that CA may provide 
relative buffering of CBF, as opposed to complete buffering (“plateau”) in the face of changing 
BP.  
 
The presence of dynamic CA was further examined through studies using transfer analysis 
(TFA) to demonstrate the various frequency domain parameters making up corresponding BP 
and CBF signals [8, 168]. With BP acting as the input and CBF acting as output, their linear 
dependence (coherence), timing (phase) and magnitudes (gain) can be determined over a variety 
of frequency ranges. Though dynamic and steady-state CA are commonly referred to as separate 
entities, it is important to remember that the two are merely functions of different experimental 
conditions and are therefore not be representative of two separate physiological mechanisms [9]. 
Greater details on methods for quantifying dynamic CA are presented beginning in section 
3.1.8.2. 
 
2.4.1 CA Mechanistic Function 
Due to the limitations of intracranial measurement, the actual physiological mechanisms 
responsible for CA are not completely understood [169]. Neurogenic, myogenic and nitric oxide 
(NO) mechanisms are all thought to play a role but a definitive depiction is yet to be reached. CA 
is commonly thought of as predominantly a myogenic response mechanism but the presence of 
sympathetic and parasympathetic innervation [170-172] and vasoactive NO [173, 174] suggest 
that the mechanism is likely not myogenic alone. All potential mechanisms should therefore be 
considered, including the viscoelastic properties of the cerebral arteries [165, 175, 176]. 
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Myogenic factors are believed to contribute to CA with the input located at the level of the 
vascular smooth muscle. The myogenic response was originally reported in 1902 by Bayliss 
[177], who observed that resistance arteries are able to constrict in response to a rise in 
intraluminal pressure. Myogenic constriction is a major determinant of peripheral resistance and 
organ perfusion and as result plays an important role in local perfusion maintenance, independent 
to systemic BP [178, 179]. Myogenic responses occur predominantly in smaller resistance 
arteries (<500 µm) [180] through depolarization of smooth muscle cells resulting in an increase 
in intracellular free calcium concentration [181]. An increase in BP activates stretch-sensitive ion 
channels and voltage gated Ca2+ channels allow the influx of Ca2+ resulting in smooth muscle 
contraction [181].  
 
Studies indicate that myogenic response plays a role in cerebral arterial resistance but is not 
likely responsible for CA in its entirety [176, 182]. In vivo human studies are limited to the use 
of L-type Ca2+ channel blockade to remove the potential myogenic response [176, 182]. Endoh et 
al. [182] demonstrated a 37% decrease in ARI in anaesthetized patients administered with 
Nicardipine, a Ca2+ channel antagonist. Tzeng et al. [176] demonstrated that nimodipine induced 
Ca2+ blockade resulted in a decrease in phase but no change in gain between MAP and mean 
CBFv, suggesting that the removal of myogenic response affects the latency but not magnitude 
of cerebral arterial buffering. Therefore, myogenic response may only account for a component 
of what is observed as integrated CA.  
 
Studies on neurogenic cerebrovascular control in healthy humans suggest that sympathetic and 
parasympathetic innervation of the cerebral arteries likely plays a role in CA [7]. The 
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cerebrovasculature is densely innervated by both adrenergic and cholinergic fibres, which are 
believed to actively modulate vessel diameter [170-172]. Supporting evidence is limited as it is 
challenging to directly quantify neural control of cerebral vessels within the cranial cavity. Few 
studies have been conducted on the role of cholinergic control CA but anatomical studies 
demonstrate dense parasympathetic innervation of the cerebral arteries [171, 172]. In humans, 
biochemical evidence has suggested that SNA influences CBF but may be a relatively trivial 
effect [183].  However, other studies employing TCD measurements demonstrate a modest 
frequency-dependent role of both sympathetic [7, 184, 185] and parasympathetic [186, 187] 
nerve activity on dynamic cerebral autoregulation. Pharmacological interventions blocking 
sympathetic activity demonstrate an increased transfer function gain and decreased phase lead in 
low frequencies (0.03Hz), suggesting a decrease in CA with the removal of sympathetic nerve 
interaction [7, 184]. Impairment of CA has been demonstrated following SNS blockade, with a 
greater increase in CBF shown for a given increase in MAP following phentolomine induced α-
adrenoreceptor block [188] or trimethaphan induced sympathetic ganglion blockade [189]. CBF 
recovery following transient hypotension is impaired with prozosin blockade of α1-
adrenoreceptors [185]. Though these studies demonstrate potential neurogenic control of the 
cerebral arteries, the use of pharmacological blockade does not rule out the possibility that 
effects seen were the result of altered systemic arterial neurogenic control. Though supportive of 
the possibility, these studies do not ascertain the role of sympathetic or parasympathetic 
regulation of CA.  
 
Local arterial nitric oxide is believed to play a role in CA as well. Human studies observing the 
role of NO mediated vasodilation on CA have resulted in conflicting results. White et al. [173] 
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demonstrate a 17% reduction in Tiecks’ Autoregulatory Index (ARI) in patients treated with L-
NMMA, a nitric oxide synthase inhibitor. Conversely, Zhang et al. [174] demonstrate no effect 
of L-NMMA inhibition on LF gain and phase using TFA. The opposing results of these studies 
may be attributed to the lack of convergence between CA quantification techniques. Regardless, 
the potential of NO playing a role in CA cannot be ruled out.  
 
Recent studies also suggest that vascular compliance may also play a bigger role in cerebral BP 
buffering than previously thought. The long prevailing paradigm proposed by Aaslid et al. [190] 
suggests that the cerebral vessels are stiff, removing the role of vascular compliance in local 
blood flow buffering. Their proposed ‘rigid-tube’ model was supported by relatively short pulse 
transit times between cerebral arteries and veins, representing limited vascular deformation. This 
concept was further supported by anatomical studies demonstrating the rigid nature of cerebral 
arteries. The tunica media and adventitia had been shown to contain very little elastin, the 
component responsible for the distensible nature of blood vessels [191, 192]. The cerebral 
arteries are highly resistant to axial deformation [193, 194] and the rigid skull compartment 
limits outward expansion in response to pressure [195]. However, more recent studies suggest 
that compliance may play a bigger role than previously thought. A more recent study 
demonstrates that the stretch properties of cerebral arteries are anisotropic, demonstrating greater 
stretch circumferentially than axially [175]. Basing theories on the axial properties may 
overestimate the stiffness of cerebral arteries. More recent studies using a Windkessel model that 
mathematically accounts for vascular compliance and suggest that it may play a bigger role than 
previously thought [165, 176, 196, 197]. These studies demonstrate that by incorporating a 
compliance reservoir when characterizing cerebral pressure-flow relationships, Windkessel 
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models are able to generate waveforms that fit closely with actual CBF recordings. Therefore, 
the potential role of vascular compliance cannot be excluded.  
 
Current quantification techniques do not have the ability to account for the various underlying 
interactions responsible for what is often interpreted as CA [198]. The active regulation of 
cerebral arterial resistance may likely be controlled by a combination of NO, neurogenic and 
myogenic factors. Further, capacitance produced by the physical stretch properties of cerebral 
arteries may also have an impact on current metrics of CA. Therefore, we acknowledge that our 
quantifications of CA are likely representative of the combined effect of the above mentioned 
factors.   
 
2.4.2 Clinical Significance of cerebral autoregulation 
CA quantification has the potential to provide predictive models for assessment of disease state 
or new details for treatment strategies. In healthy individuals, CA provides quick local 
modulation of CBF in the presence of acute BP perturbations, providing a relatively stable CBF. 
A decreased ability to do so may be associated with adverse cerebrovascular health. Assessment 
of CA may provide valuable information on an individual’s ability to maintain adequate cerebral 
blood flow and has been studied in relation to a number of clinical scenarios including 
orthostasis [167, 199], central hypovolemia [200], ischemic stroke [201], intracranial 
hemorrhage [156] and traumatic brain injury (TBI) [202, 203].  
 
Studies demonstrate that CA is diminished in ischemic stroke, intracranial hemorrhage and TBI, 
which may in part play a role in the reduction in CBF associated with these conditions. Acute 
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ischaemic stroke has been associated with a decreased dynamic CA and this impairment is 
global, not just related to the affected hemisphere [201]. Similarly, intracranial hemorrhage [156] 
and TBI [202, 203] have also been associated with a decreased CA. Impaired CA has been 
reported following even mild TBI [204] and disturbed CA has been associated with unfavorable 
outcome [205]. The brain may be at greater risk of secondary insults and less capable of 
maintaining CBF with the decrease in CA observed in these conditions.  
 
Current studies on the clinical relevance of CA aim to provide better understanding of normal 
and abnormal CA function in relation to challenges such as orthostatic hypotension and 
hypovolemia. The relationship between CA and initial orthostatic hypotension (IOH) has been 
studied comprehensively in healthy subjects, demonstrating that IOH is experienced in most 
healthy subjects, with considerable reductions in CBFv when moving from supine to stand [206]. 
But regardless of being symptomatic or asymptomatic in response to IOH, young healthy 
subjects demonstrate no difference in CA [206]. Similarly, comparable CA values are found in 
subjects having both high and low tolerance tolerance to simulated hypovolemia [207]. These 
studies demonstrate that individuals having a high CA may still have a low tolerance to 
orthostatic hypotension or hypovolemia, suggesting that CA alone may not dictate tolerance to 
hypovolemia. 
 
CA has also been studied in relation to syncope and despite being somewhat controversial, it has 
been proposed that the hemodynamic collapse preceding syncope is associated with a decrease in 
CA [208]. Early investigations suggest that CA is disrupted at the time of faint during syncope in 
both adults [208] and children [209] but much of this steady-state reduction in CBF was 
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attributed to vasoconstriction induced by hypocapnia [210-212]. Schondorf et al. [213] later 
demonstrated that CA remained intact during syncope but this was refuted by Carey et al. [211]  
and more recently by Ocon et al. [214] who both demonstrated a decrease in CA immediately 
before and during time of faint temporally related to VVS.  
 
The assessment of CA in relation to clinical scenarios may provide information on an 
individual’s ability to locally regulate CBF. While CA may be diminished in clinical scenarios 
such as stroke and TBI, it may not be a great predictive tool for quantifying risk of 
cerebrovascular conditions on its own. CA may not be indicative of tolerance to conditions such 
as orthostatic intolerance or hypovolemia [206, 207]. Additionally, the lack of a gold standard 
technique for quantifying CA may result in discrepancies in results depending on what technique 
is used [215]. The quantification of CA does not take into account the potential role of the 
baroreflex in maintenance of CBF. Accounting for both reflex mechanisms may provide greater 
understanding in studies on clinical conditions affecting CBF. 
 
2.5 CA and Baroreflex Interactions 
Though both the baroreflex and CA have been studied extensively, little work has been done to 
better understand the potential integration between the two systems. Recent studies have 
documented an inverse relationship between dynamic CA and cardiac BRS showing that healthy 
individuals with an attenuated CA likely have a high baroreflex sensitivity (BRS) and vise versa 
[13, 14]. This divergence may reflect an integrated compensatory relationship between the two 
mechanisms directed at maintaining optimal CBF in the presence of excessive BPV. Under this 
concept, subjects having a poor BRS or CA function may still be able to maintain adequate CBF 
	 30	
due to an increased presence of the other mechanism. These associations suggest that the 
dispersion typically seen in individual flow-regulating mechanisms may be explainable through 
functional equilibrium existing between redundant regulatory systems.  
 
These two previous studies demonstrate an inverse relationship between cardiac BRS and CA 
using a range of different CA and BRS quantification techniques in different subject groups. 
Tzeng et al. demonstrated a significant inverse relationship between BRS as quantified with Gup, 
GDown, and alpha index metrics through the modified Oxford method and CA quantified via RoR, 
ARI and TFA gain metrics in healthy young subjects [13]. The variety of metrics used to 
quantify both BRS and CA in their study suggests that the observed relationship is not metric 
dependent. Recently, Nasr et al. also demonstrated a similar inverse relationship in older healthy 
subjects and patients with unilateral atherosclerotic stenosis or occlusion, quantifying cardiac 
BRS through the sequence method and CA as the correlation coefficient between slow 
oscillations in MAP and mean CBFv [14]. Their results further suggest that the relationship is 
not metric dependent and is similar in an older subject cohort. Additionally, their quantifications 
of BRS are derived from spontaneous baseline data, demonstrating that their results are not 
dependent on pharmacological effects of SNP or PE. Together these studies provide a strong 
case for the inverse relationship between the cardiac baroreflex and CA.  
 
In addition to an inverse relationship between CA and cardiac BRS, Tzeng et al. [13] 
demonstrate an inverse relationship between BPV and BRS and a positive relationship between 
BPV and CA. This suggests that subjects with a greater BPV, perhaps due in part to a diminished 
BRS, may employ a compensatory augmentation of CA to ensure that CBF is maintained in the 
presence of BP fluctuations. BPV is an important physiological endpoint, as significant increases 
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or decreases in systemic BP can lead to cerebral hypoperfusion or hyperperfusion. With 
diminished baroreflex or CA buffering, this can lead to infarct extension, stroke, or hemorrhagic 
transformation of a preexisting stroke [201, 216]. The results presented by Tzeng et al. [13] 
suggest that individuals with a diminished baroreflex are able to buffer the effects of BPV on the 
cerebral circulation via an augmented CA.  
 
While these studies demonstrate a functional relationship between CA and the baroreflex in 
humans, they only account for the cardiac component of the baroreflex. In addition to an increase 
in cardiac parasympathetic outflow, mechanical deformation of barosensory vessels elicits a 
decrease in sympathetic vascular tone. It has been suggested that the latter may play a greater 
role in acute blood pressure regulation [217, 218] and the cardiac and sympathetic arterial 
components of the baroreflex do not necessarily relate to one another [15]. Therefore, 
conclusions based on cardiac baroreflex function may not necessarily extend to sympathetic 
control of blood pressure [15]. To fully depict the relationship between the baroreflex and 




Figure 2.6. Relationship between cardiac baroreflex sensitivity derived from nitroprusside (NP BRS), phenylephrine 
(PE BRS), and low-frequency α-index against CA as quantified by RoR and ARI. Each Point represents an 
individual subject. A clear inverse relationship is present between BRS and CA. Adapted from Tzeng et al. [13]. 
 
Thus, the primary objective of this experiment is to demonstrate the relationship between the 
sympathetic vascular baroreflex and CA. Our operating hypothesis is that sympathetic vascular 
BRS and CA will be inversely related in normal healthy young males.   
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Chapter 3. Methods  
3.1 Methodology 
3.1.1 Recording Techniques 
 
3.1.1.1 ECG 
We recorded electrocardiogram (ECG) to quantify beat-to-beat R-R interval. Cardiac contraction 
is dependent on structured flow of electrical impulses through myocardial tissue, which can be 
easily recorded through the use of ECG. ECG recordings can provide a multitude of information 
on cardiac structure and function and have been in use clinically since the early 1900’s [219]. 
ECG use is now an essential diagnostic tool in clinical settings and proves useful in research as it 
provides a noninvasive and accurate depiction of cardiac contractile activity. ECG plays a 
fundamental role in this experiment, both for recording cardiac contractile activity and 
associating corresponding BP, CBFv, and MSNA together.   
 
Early studies on electrical activity in skeletal muscle and the heart played an important role in the 
development of ECG. Electrical current in skeletal muscle was first observed by Dr. Luigi 
Galvani in 1786 [220] and in 1842, Dr. Carlo Matteucci demonstrated that heart beats are 
associated with corresponding electrical activity in frogs [221]. In 1887, Augustus Waller made 
the first recording of human heart electrical activity, demonstrating that ventricular contraction is 
preceded by electrical activity [222] and shortly after, William Bayliss and Edward Starling 
demonstrated triphasic cardiac electrical activity associated with each heart beat using a capillary 
electrometer [223, 224].  
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The advent of ECG in its current form is due largely to the work of Dr. Willem Einthoven, who 
refined the capillary electrometer and was able to break the recorded signal down to five separate 
deflections. He implemented a mathematical correction to account for inertia in the capillary 
system and named the adjusted deflections P, Q, R, S and T, which are the deflections observed 
in current ECG recordings [225, 226]. Early ECGs used 5 electrodes, including one for each limb 
and one for the mouth and resulted in 10 leads from all combinations. Einthoven reduced the 
number of electrodes down to three, as the mouth and right leg electrodes did not yield much of a 
signal. The three-electrode system and resulting three leads were used to construct Einthoven’s 
triangle [227].  
 
The use of the three lead ECG allows for the detection of arrhythmias, irregular heartbeat, or 
even myocardial infarction. Modern clinical ECG’s are typically conducted with a more 
advanced 12 lead system, as the greater number of leads is able to detect a greater number of 
cardiac abnormalities. We use a 3 lead system, as the additional information from the 12 lead 
system is not relevant to our experiment. For our experiment, we detect and quantify each QRS 
complex as one cardiac cycle, which allows us to quantify changes in R-R interval as well as 
correspond all BP, CBFv and MSNA data associated with each cardiac cycle.  
 
3.1.1.2 Finometer Blood Pressure 
We measured continuous noninvasive BP through the use of a Finapres Finometer finger BP 
cuff. This method provides noninvasive continuous BP data and has been validated against 
continuous beat-to-beat intra-arterial BP recordings [228-230]. Prior to the advent of 
photophlesmography, researchers were limited to invasive arterial BP measurements as the only 
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option for continuous BP measurement. The finometer makes continuous BP quantification more 
accessible and easier to conduct, not requiring the additional skills or risks of intra-arterial BP 
measurement. 
 
The finometer instrument uses the Penaz volume clamp method in which an infrared 
photoplethysmograph measures blood volume under an inflatable finger cuff [228] and consists 
of a finger cuff, a valve regulating cuff fluid pressure and a manometer to read cuff pressure. The 
wrap-on cuff consists of a small plastic foil air bladder, Velcro for fixation and a 
plethysmograph, which consists of a light-emitting diode (LED) and photodiode receiver resting 
on opposite sides of the finger. A small air hose runs from the cuff to a small box containing a 
control valve, pressure transducer and plethysmographic preamplifier connected to a servo 
system. Through the measurement of blood volume changes, the Finometer accurately quantifies 
noninvasive beat-to-beat changes in BP throughout each recording.  
 
This technique has been validated in a number of studies comparing simultaneous Finometer and 
intra-arterial recordings to one another [228, 229, 231]. One review paper uses the results from 
43 papers evaluating the relationship between Finometer and intra-arterial BP to provide a 
weighted average. Combined, these studies are comprised of 1031 total subjects and produces an 
average weighted accuracy of -0.8 ± 11.7 mmHg for SBP, -1.6 ± 8.5 mmHg for MAP and 1.6 ± 
7.7 mmHg for DBP [231]. For quantifying BPV, the Finometer has also been validated against 
intra-arterial measurement [230]. While SBP standard deviations are larger at the finger, both 
finger and intra-arterial measurement produce similar MAP and DBP standard deviations. 
Spectral analysis conducted on the Finometer and intra-arterial measurements produces similar 
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DBP and MAP variability in all frequency ranges. For SBP, the Finometer was found to 
overestimate very low frequency (VLF) and low frequency (LF) components but similar values 
are still observed in the high frequency (HF) band [230, 232]. These results demonstrate that the 
Finometer is a reliable alternative to invasive BP measurement for the assessment of beat-to-beat 
BP changes, with significant variation only observed in VLF and LF systolic BPV.  The use of 
Finometer measurement is useful for our study as it provides high fidelity accurate BP recordings 
throughout all testing conditions, a key measurement for all quantifications of CA and BRS in 
this experiment.  
 
3.1.1.3 Transcranial Doppler Ultrasound 
TCD is used to quantify CBFv as a surrogate of CBF. TCD works under the same general 
principles of the Doppler effect and provides a noninvasive measurement of blood flow velocity 
in large cranial vessels. This is done through the use of an ultrasonic beam produced by a 
piezoelectric transducer of 2MHz. Because TCD only provides velocity information and not 
vessel diameter, it does not quantify actual CBF. As result, any diameter changes in the 
insonated blood vessel would cause changes in CBFv to not be representative of changes in CBF 
[233]. However, previous studies have demonstrated that the diameter of the large cerebral 
vessels including the middle cerebral artery (MCA) does not change under either resting or lower 
body negative pressure conditions [234-236].  Therefore, CBFv can be used as a surrogate 
measure of CBF but consideration of the potential for discrepancy should be made. 
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Figure 3.1. TCD recording of CBFv of the middle cerebral artery. Reproduced from Aaslid, 1982 [237]. 
 
TCD ultrasound allows for measurement of blood flow velocity in large cerebral vessels and is 
based on principles and assumptions common to other Doppler blood flow velocity methods 
[233]. Insonating ultrasonic pressure waves are reflected by moving red blood cells (figure 3.1) 
and their velocity is directly proportional to the detected ultrasonic frequency shift [233]. The 
velocity distribution across the vessel diameter is parabolic in the presence of laminar flow and 
as a result, the detected Doppler frequency shift is present as a distribution of frequencies. A fast 
Fourier transform (FFT) algorithm is typically applied to obtain the spectral distribution and 
frequency of the signal. Through the use of the FFT, either an intensity-weighted mean or 
maximum frequency can be obtained to represent the mean velocity for a given time series of 
data. 
 
One of the challenges of conducting Doppler measurements of the cerebral vasculature is getting 
Doppler sound waves to penetrate superficial tissue. The majority of ultrasound radiation is 
reflected or absorbed by the skull. However, the discovery of acoustic windows, regions of the 
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skull that are thin enough for ultrasound penetration, provided the ability to image blood flow 
velocity in various cerebral arteries. The transtemporal window, located just above the zygomatic 
arch, is most commonly used for quantification of CBFv as the MCA, posterior cerebral artery 
and anterior cerebral artery are all most easily accessed there [233].  
 
To start, the right MCA is insonated at an initial depth of ~50mm through the temporal bone 
widow above the zygomatic arch. A successful sonogram of the MCA is decided by a number of 
factors. First, a positive, pulsatile velocity pattern will indicate that blood flowing through the 
insonated vessel is travelling towards the probe. Blood flowing through the MCA travels towards 
the temporal window. Second, continuous traceability should remain throughout the depth of 
insonation. In most healthy subjects, reducing the depth to the minimum insonation and slowly 
increasing again should not alter the signal pattern or velocity amplitude until it gets to ~55mm 
or greater. The MCA is the only vessel in the temporal window that can show a constant velocity 
signal over a range of depths greater than 20mm [233]. Additionally, the MCA should 
demonstrate the highest velocity of all basal vessels in the temporal window [238-240].  Once 
the MCA CBFv trace meets these criteria, the probe is held in place for the duration of the study 
with custom made headgear.  
 
3.1.1.4 End tidal CO2 
PaCO2 is a key regulator of cerebral perfusion, with hypercapnia and hypocapnia causing an 
increase or decrease in CBF respectively[234, 241]. As result, altererations in PaCO2 affect CA 
quantification. Aaslid et al. [6] demonstrated that hypocapnia (~22 mmHg) doubles the rate of 
regulation index (RoR) index and hypercapnia (~47 mmHg via 5% CO2 inhalation) causes RoR 
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to decrease up to 45%. This suggests that CA is altered with manipulation of PaCO2. Using end 
tidal CO2 (ETCO2) as a surrogate of PaCO2, another study demonstrates that other than LF n-
gain and phase, most TFA metrics were affected by changes in ETCO2 ranging from -5 mmHg to 
+5 mmHg [242]. Therefore, PaCO2 levels must be quantified in some way to ensure that it stays 
consistent throughout each measurement.  
 
PaCO2 quantification is typically conducted through the use of intermittent arterial blood 
sampling [243]. However, intraarterial blood gas measurement is an invasive procedure and has 
the potential to be associated with substantial blood loss [244, 245]. Capnographic measurement 
of end tidal CO2 (ETCO2) is commonly used as a surrogate of PaCO2 as it provides a continuous 
noninvasive measurement. Because changes in ETCO2 are consistent with changes in PaCO2 in 
supine, resting conditions [246-248], ETCO2 is used in this study as a continuous surrogate of 
PaCO2.  
 
Capnography is based on the ability of CO2 to absorb infrared (IR) radiation. Due to the 
molecule’s asymmetry and polyatomic nature, it absorbs a greater amount of IR light compared 
to other molecules. IR measurements of CO2 were first conducted in the mid-1800’s by John 
Tyndall through his development of the first ratio spectrometer [249, 250]. This device provided 
the ability to quantify IR absorption of gas and vapor samples allowing quantification of gas 
concentrations, such as CO2, for a given sample [251]. Over the next century the concept of his 




Modern CO2 analyzers are still based on the same principle IR technology, recording changes in 
IR absorption to determine the concentration of CO2 sampled from a nasal line or mask. The CO2 
concentration in a given sample is determined through measuring radiation intensity with an 
infrared detector. For our study, end tidal CO2 was sampled from a nasal line  (gas analyzer 
model ML206, ADInstruments, Colorado Springs, CO) and monitored to ensure that PaCO2 
stayed constant. ETCO2 should not affect inter-individual CA results if it remains relatively 
constant under baseline and thigh cuff deflation testing conditions.  
 
3.1.1.5 Muscle Sympathetic Nerve Activity 
MSNA is recorded through the use of microneurography, which is the process of percutaneously 
inserting a tungsten microelectrode into a nerve to record action potentials [101, 252, 253]. This 
is typically conducted in accessible peripheral nerves such as the peroneal or median nerves and 
has been conducted in cranial nerves as well [103]. Microneurographic recordings are conducted 
through the use of tungsten microelectrodes with a shaft diameter of about 200 µm and a tip 
diameter of about 5 µm [103]. The microelectrodes are insulated except for the tip. The limited 
area of uninsulated tungsten provides a smaller focal range and therefore a smaller, more specific 
recording region of the nerve observed. Higher impedance means that an electrode has a smaller 




Figure 3.2. Peroneal nerve MSNA recording setup. a.) Ground electrode b.) Fibular head c.) Preamplifier d.) 
Recording electrode, inserted into the peroneal nerve posterior to the fibular head e.) Peroneal nerve location, as 
determined by external electrical stimulus 
 
Initial location of the nerve-recording site is typically done through the use of brief pulsing 
electrical-stimulus with a surface electrode. The initial stimulus is started anywhere between 2-
10 mA and is decreased as necessary. The most optimal site for microlectrode insertion tends to 
be the point at which the lowest electrical stimulus evokes twitches in the innervated muscle. 
Once the microelectrode site is located, a subdermal microelectrode is placed approximately 1 
cm from the site to act as a reference. This electrode has approximately 1mm of insulation 
removed from the tip. The recording microelectrode is inserted at the chosen site and guided 
towards the muscle nerve fascicle by intraneural stimulation (Figure 3.2). After initial insertion 






at 0.01 mA and gradually increasing towards 1 mA until muscle twitches are evoked. 
Adjustments are made to the recording microelectrode until the stimulus evokes muscle twitches 
at 0.02 mA or less, an indication that the microelectrode tip is within the muscle nerve fascicle 
[103]. 
 
Once the microelectrode is within the desired muscle nerve fascicle, optimal location is 
determined by sound and visualization of the burst recordings in response to physical tests. 
Tapping or stretching the innervated muscle helps to further guide by providing indication of 
whether or not the microelectrode is in the right location. Closer proximity to the muscle spindle 
afferents will result in greater visual and audible peaks in the nerve signal. To ensure that the 
recorded nerve is indeed a muscle fascicle, the subject is asked to perform the Valsalva 
maneuver or apnea. These techniques increase MSNA but not SSNA [103].   
 
 
Figure 3.3. Sample raw and integrated muscle sympathetic nerve activity recordings. Nerve activity occurs as 
bursts. Integration of the raw MSNA recording is typically required for analysis, as it makes manual or automated 






Early microneurographic recordings demonstrate that sympathetic nerve activity occurs in bursts 
[105, 106]. Figure 3.3 demonstrates a sample raw MSNA recording and it’s corresponding 
integrated signal.  There are numerous methods employed for quantifying MSNA. The most 
common quantification of MSNA is to count the number of bursts per minute (burst frequency) 
or per 100 heartbeats (burst incidence). For our analysis, we quantified integrated area, providing 
information on burst size as a further layer of detail [254].  
 
The baseline MSNA signal is not zero in between bursts and therefore must be accounted for 
when quantifying burst activity. It is common to estimate the baseline zero level during response 
to a vasoconstrictor such as phenylephrine [255, 256]. The gold standard technique for 
determining MSNA background noise level and zero baseline is to measure mean MSNA 
activity during ganglionic blockade [257]. Ganglionic blockade prevents burst activity allowing 
the average of a greater length of baseline data, providing a highly accurate zero value. However, 
the use of ganglionic blockade is not always practical.  The use of MSNA activity in between 
bursts can be used and has been shown to have a very close relationship to MSNA baseline 
calculated during ganglionic blockade and has been suggested to be an acceptable technique for 
calculating the zero value. Alternatively, if there is a limited amount of MSNA signal without 
bursts to use, the zero value can also be taken as the average of minimum MSNA values during 







3.1.2.1 Spontaneous Baseline 
Spontaneous baseline measurements were recorded with the subject resting horizontally and 
continuous TCD, ETCO2, ECG, BP, and MSNA were recorded for 5 minutes (Figure 3.4). The 
data collected from this segment was used to quantify TFA metrics, spontaneous sympathetic 
BRS, spontaneous MSNA, BPV and HR variability. The use of spontaneous data for BRS 
quantification eliminates pharmacological influences.  
 
Figure 3.4. Representative spontaneous baseline recording. BP, RR interval, CBFv at the middle cerebral artery 
(MCAv) and MSNA at the left peroneal nerve recorded during 5 minutes of supine rest. 
 
3.1.2.2 Modified Oxford 
BRS was assessed through the use of the modified Oxford method [98, 258, 259]. The modified 
Oxford technique is the gold standard technique for quantifying BRS and is conducted by 
monitoring MSNA and ECG responses to pharmacological BP perturbations. As studies suggest 








































understand baroreflex reaction outside of its normal resting threshold BP range [260-263]. Initial 
use of pharmacological assessment of the baroreflex was conducted by Smyth et al. [264], who 
generated a pressor response via the “Oxford” method, using venous bolus of angiotensin. 
Subsequent studies induced pressure changes via PE induced vasoconstriction [265], SNP 
induced vasodilation [266], and later, Ebert developed and employed the “modified Oxford” 
technique, creating a BP rise and fall via sequential bolus injection of SNP and PE [267]. This 
technique is advantageous as it provides a response to both rising and falling BP in a single 
sequence (Figure 3.5). Additionally, the modified Oxford technique provides a greater, longer 
pressure rise than phenylephrine alone as used in the original Oxford technique [98]. Quantifying 
baroreflex response to pharmacological intervention is considered most optimal, as there is a 
clear cause and effect in baroreflex-mediated response. This consisted of sequential intravenous 
bolus injections of 200-µg SNP followed 60 seconds later by 200- to 300-µg PE. Recording 
stopped when SBP began to plateau after the rise after PE injection. SBP values were matched to 
the corresponding heart beat for R-R intervals > 800ms or a one second delay for shorter heart 
beat < 800ms in order to account for baroreflex delays [268, 269]. All subjects underwent at least 
two valid test trials. Modified Oxford test trials were separated by a washout period of at least 15 
minutes to ensure adequate stabilization of BP. Trials were considered valid if the resulting drop 
and rise in BP was >15mmHg compared to their baseline values. 
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Figure 3.5. Modified Oxford recording. BP, RR interval and MSNA response to back-to-back bolus injections of 




3.1.2.3 Thigh Cuff Deflation 
Thigh cuff deflation is used as a stimulus for the quantification of CA and was first introduced 
by Aaslid et al. [6]. This technique uses the rapid decrease in blood pressure following thigh cuff 
deflation to compare BP and CBFv responses to a transient drop in blood pressure (Figure 3.6). 
The step decrease in BP and CBFv are introduced by inflating bilateral thigh cuffs to a 
suprasystolic pressure, cutting off arterial and venous circulation to the lower legs. The cuffs are 
left inflated for 3 minutes for BP and CBFv to stabilize. After 3 minutes, the cuffs are rapidly 
deflated causing a hydrostatic gradient. The hydrostatic gradient in a momentary decrease in BP 
in the upper extremities and CBFv, as blood moves towards the momentary lower pressure of the 































Figure 3.6. Thigh cuff deflation. Blood pressure, RR interval and cerebral blood flow velocity of the middle 
cerebral artery following after bilateral thigh cuff deflation. Cuffs were inflated to a suprasystolic pressure for 3 




3.1.3.1 Baroreflex Quantification 
A number of techniques are available for BRS quantification. Most studies only focus on the 
cardiac or sympathetic arterial baroreflex individually. Studies conducted on cardiac BRS are 
more common as it does not require the addition of highly technical and time-consuming MSNA 
measurement. While both cardiac and sympathetic arterial baroreflex are derived from the same 
input, it has previously been demonstrated that there is no correlation between the two [15].  
 

































falling and rising BP have different slope value. This phenomenon is termed hysteresis and has 
been demonstrated previously through the neck pressure [97] and modified Oxford [98] 
techniques.  Gdown begins at the onset of decrease in Systolic BP after SNP injection and ends 
when systolic BP reached its lowest point. Gup begins at the same lowest point systolic BP and 
ends at the systolic BP peak after bolus PE injection.  
 
Previous studies assessing sympathetic arterial BRS have either separately analyzed the SNP 
induced decrease in BP and PE induced increase in BP to account for hysteresis [270] or have 
used the entire recording from initial drop in BP through the return to baseline to produce a 
single BRS slope value [98]. We could not demonstrate hysteresis as we could not obtain 
significant Gup  and Gdown slopes individually for most of our subjects. Therefore, we combined 
both Gup  and Gdown segments for each Modified Oxford trial. This allowed for a greater number 
of cardiac cycles accounted for in each pressure range, resulting in a more accurate BRS slope. 
 
For the analysis of sympathetic arterial BRS, we used a custom automated analysis program 
written in LabVIEW. Data analysis for sympathetic BRS is typically conducted by hand but 
doing so is disadvantageous for a number of reasons. Manual analysis is a time consuming and 
objective process. The process of manually analysis requires an experienced technician to 
determine whether each individual cardiac cycle is synchronized with an MSNA burst and assign 
each to its corresponding diastolic pressure. An inter-individual variation of 9% for analysis of 
the same data has previously been reported [271]. Additionally, the operator can miss smaller 
sympathetic bursts in noise typical to MSNA recordings. Though a number of methods are 
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available for sympathetic BRS analysis, we developed a method based largely on a method 
employed by Halliwill [272]. 
Figure 3.7. Signal Averaged Analysis of MSNA during Modified Oxford. MSNA activity corresponding to each 
ECG R peak (dotted line) were binned according to DBP. Average integrated MSNA was plotted for each 3mmHg 
pressure bin.   
Arterial BRS was assessed as the relationship between DBP and normalized MSNA activity 
during both the modified Oxford method ad spontaneous baseline, as MSNA is more closely 
associated with DBP than with SBP or MAP [104]. MSNA signals were normalized as baseline 
and burst amplitude vary depending on electrode placement [111, 273]. For the normalization, 
the largest burst occurring during baseline recording was given an arbitrary amplitude of 1000. 
MSNA activity for the entire recording was then calibrated to this amplitude.   The MSNA signal 
corresponding to each cardiac cycle was segregated into 3mmHg DBP bins, factoring out the 















































pressure bin was then plotted against DBP (Figure 3.7). The slope of the line of best fit was taken 
as arterial BRS. The slope of the linear regression was only used if it’s correlation coefficient 
was R>0.8. BRS estimates were taken as the average of the two trials.   
 
3.1.3.2 Cerebral Autoregulation Quantification 
The concept of dynamic CA led to the development of new methods for its quantification. 
Though the CA analysis techniques produced over the past couple of decades generally are 
mathematically unique to one another and vary in the amount of detail provided, they all serve a 
similar purpose in providing an index of cerebrovascular ability to buffer BP perturbations. 
Three methods in particular have gained popularity and they are rate of regulation (RoR), ARI 
and TFA.  
 
3.1.3.2.1 Tiecks’ Autoregulatory Index 
 
Figure 3.8. Tiecks’ autoregulatory index quantification. 9 possible cerebral blood flow velocity responses to drop in 
blood pressure calculated. Number of closest theoretical response to actual response is used as index value. 











ARI quantifies CA based on a model incorporating both latency and gain. ARI is based on a 
second order differential equation and provides a single number index of autoregulation. ARI is 
derived by fitting a 30 second window of both MAP and CBFv post hypotensive stimulus to a 
mathematical model incorporating both gain and latency. From the model, ten template models 
of CBFv response based on the post-hypotensive MAP are produced, representing each integer 
from 0 to 9 (Figure 3.8), with 0 representing no cerebral buffering capacity and 9 representing a 
strong cerebral buffering capacity. The index of the model curve best fitting the actual CBFv 
response is the subject’s ARI value. To do this, the following second-order differential equation 
is applied:  
dPn = MAP-MAPbase/MAPbase-CCP 
x2n = x2n + (x1n – 2D x2n-1)/f*T 
x1n = x1n-1 + (dPn – x2n-1)/f*T 
mVn = MCAVbase * (1 + dPn – k *x2n) 
where dPn is the normalized change in MAP relative to control value (MAPbase), adjusted for 
estimated critical closing pressure (CCP) of 12mmHg [159], x2n and x1n are state variables 
(equal to 0 at baseline), mVn is modeled mean velocity, MCAvbase is baseline MCAvmean, f is the 
sampling frequency (1000Hz) and n is the sample number. The mVn generated from 10 
predefined combinations of parameters T (time constant), D (dampening factor), and k 
(autoregulatory gain) that best fit (30-s window; quadratic error) the actual MCAvmean recording 
was taken as an index of dynamic CA. Tiecks’ ARI is commonly used for analysis of thigh cuff 
deflation but has been shown to work in other maneuvers such as sit-to-stand induced 
hypotension [167] and  spontaneous BP fluctuations [274].  
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3.1.3.2.2 Transfer Function Analysis 
TFA relates dynamic BP and CBF changes over a range of time scales in the frequency domain, 
allowing for the observation of cerebral blood flow buffering in relation to changes in arterial 
pressure over a variety of frequency ranges (Figure 3.9). TFA provides information about the 
phase, gain and coherence of the relationship between BP and CBF in various frequency ranges. 
Coherence between BP and CBF is usually below 0.5 in the very low frequency range (VLF, 
0.02-0.07 Hz), indicating that BP can only predict 50% of flow velocity variance in this range. 
The high frequency range (HF, 0.20-0.40 Hz) coherence is higher and low frequency range (LF, 




Figure 3.9. Transfer function analysis between spontaneous blood pressure and cerebral blood flow velocity 
fluctuations for one representative subject. MAP, mean arterial pressure; MCAv, middle cerebral artery blood flow 
velocity; VLF, very low frequency (0.02-0.07 Hz); LF, low frequency (0.07-0.2 Hz); HF, high frequency (0.2-
0.4Hz). 
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Coherence represents the reliability of the gain and phase estimates for each frequency range and 
is a common test of linearity. Squared coherence ranges from zero to one, with a more linear 
relationship between input and output being closer to one. Low coherence close to zero can 
indicate no relationship between input and output. However, low coherence can result from other 
factors such as excessive signal noise, systemic non-linearity, or no relationship between the 
input and output [8, 168, 276]. These possible factors must be considered when interpreting 
coherence results.   
 
Phase is representative of the time relationship existing between BP changes and CBF changes 
[8] and can be quantified in degrees, radians or even time if the cycle period is known. A smaller 
phase is representative of a more linear relationship between BP and CBF whereas a larger phase 
represents a greater amount of time between the two signals. Phase can be both positive and 
negative, with positive values demonstrating changes in BP leading changes in CBF and negative 
values representing CBF changes leading BP changes. Phase is typically larger and positive in 
lower frequencies and much smaller in higher frequencies supporting the concept that CA 
functions as a high-pass filter.  
 
TFA gain, or transfer magnitude, is representative of the amplitude ratio between the output 
CBFv and input BP at each frequency range. In the case of BP and CBFv, gain represents the 
dampening effect of CA on BP oscillation magnitude. A greater attenuation of the input 
amplitude is represented by a lower gain value. As result, a low gain is used to represent highly 
efficient CA and vise versa. However, inter-individual differences in gain can be misinterpreted 
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as absolute gain measurement is influenced by the baseline BP and CBFv values. Therefore, gain 
is often normalized to account for absolute differences from subject to subject. Normalized gain 
(nGain) is quantified as the product of gain and cerebrovascular resistance (CVR), which equals 
mean BP divided by mean CBF [277-279]. Because gain represents the magnitude of BP’s effect 
on CBF, it is our primary metric of CA obtained from TFA.  
 
Higher values of phase and lower values of coherence and gain are representative of greater CA 
and vise versa. These metrics are typically quantified in three frequency ranges, VLF (0.02-
0.07Hz), LF (0.07-0.2Hz) and HF (0.2-0.4Hz) (Figure 3.9). Various cardiovascular effectors 
cause rhythmic BP oscillations in each frequency range. HF oscillations are associated with 
respiration modulated BP fluctuations while LF oscillations are associated with Mayer waves, or 
fluctuations attributed to baroreflex modulation[280]. In general, phase, gain and coherence all 
vary depending on the observed frequency range suggesting that CA operates in a frequency 
dependent manner in response to the BP oscillations in each frequency range [8]. In this sense, 
CA appears to work as a high pass filter, allowing higher frequency perturbations to pass from 
BP to CBF while buffering perturbations in the lower frequencies.  
 
In the HF range, coherence and gain tend to be high, indicating that CBFv changes in parallel 
with BP and there is very little dampening between the two scales. Additionally, phase tends to 
be low, demonstrating very little difference between the time it takes CBFv or BP to respond to a 
sudden change. Together, the information gathered from gain, coherence and phase indicate that 
CA is ineffective in the HF range as CBFv appears to have little to no buffering effects in 
response to BP perturbations.  
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Conversely, TFA metrics support the presence of CA in the VLF range. Gain tends to be low in 
this range, suggesting that CBFv is dampened in response to VLF BP fluctuations. In this range, 
coherence is <0.5. It is important to consider these possibilities as measurement noise or 
nonlinearity of the system would violate the fundamental assumption of the linear transfer 
function. The coherence is usually high in the LF and HF ranges, so the low coherence seen in 
the VLF range is not likely due to measurement noise. Perfect autoregulation would result in a 
coherence of zero with no changes in CBFv in response to changes in BP. Zhang et al. [8] 
suggest that low VLF coherence may be a result of CA induced nonlinearity between CBFv and 
BP.  
 
LF gain, phase and coherence produce more complex findings. Slow variations in BP are filtered 
out in the LF range, but not to the same degree as in VLF. Both gain and coherence are higher 
than in VLF and phase lead decreases, suggesting that the capacity of CA weakens slightly in 
this range.  Zhang et al. [8] proposed that the LF range is dependent on a complex mixture of 
both CA and biophysical properties of the cerebrovasculature. Because MAP fluctuations in the 
LF range are independent of respiratory or cardiac frequencies, LF range is believed to reflect 
autoregulatory mechanisms [8, 13, 281, 282] and is the primary frequency range observed for 
this study.  
 
The methods for quantification of dynamic CA all provide a greater level of detail on CA 
function than previous static CA measurement techniques. The ability to measure both the timing 
and the degree of buffering allows for a better depiction of the beat-to-beat interactions between 
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BP and CBFv. The use of TCD and finometer BP devices allows for easy noninvasive 
measurement in human subjects. As a result, RoR, ARI and TFA are frequently employed 
individually to depict CA in clinical scenarios.  However, the results of each technique do not 
always correspond to one another. A previous study demonstrates a lack of convergent validity 
between many of the metrics of CA including RoR, ARI and TFA coherence, phase and gain 
[215]. The lack of metric convergence suggests that individual indexes of CA may not be 
comparable to one another and may ultimately provide inconsistent physiological or clinical 
information. However, in the absence of an accepted gold standard, quantifying CA through 
multiple techniques will ensure that the relationships observed in this study are not metric 
dependent.  
 
3.2 Experimental Protocol 
3.2.1 Subjects 
14 male subjects participated after providing written informed consent. All subjects were 
normotensive (blood pressure < 140/90 mmHg) nonsmokers having no prior evidence of 
cardiopulmonary disease as based on physical examination and history. The subjects’ mean age 
was 24.4 (range 19-29 yr). All subjects had abstained from caffeinated food and beverages and 
exercise for at least 12 hours prior and were advised to have a light breakfast at least 2 h before 
the study commencement at 0800. Subjects were informed of the procedures and potential risks 
involved prior to their written consent. Individuals with very high (>140/90) or very low 
(<100/60) resting blood pressure, previous history of stroke, brain surgery or severe head trauma 
were excluded, as were obese individuals. The study was approved by University of Otago’s 




3.2.2 Measurements  
 
Figure 3.10. Experimental Setup. a.) Microneurography at left peroneal nerve, b.) Inflatable thigh cuffs for thigh 
cuff deflation, c.) Finapres continuous blood pressure recording, d.) Cannula site for drug injection, e.) Transcranial 
Doppler ultrasound, f.) Electrocardiogram, g.) Automated blood pressure cuff device for intermittent brachial blood 
pressure and estimated central arterial pressure recordings. 
 
 
Continuous recordings were collected using arterial blood pressure via finger 
photoplethysmography (Finometer MIDI, Finapres Medical Systems, Amsterdam, Netherlands), 
3 lead electrocardiogram, CBFv of the right middle cerebral artery (2-MHz pulsed Doppler 
ultrasound, ST3 Digital Transcranial Doppler System, Spencer Technologies, Seattle, WA), and 
partial pressure of end-tidal CO2 sampled from a nasal line (gas analyzer model ML206, 








photoplethysmography was performed before each recording to ensure accuracy of measurement 
and was also verified against pneumatic brachial artery blood pressure measurements 
(Cardioscope II, Pulsecor, Auckland, New Zealand). The transcranial Doppler probe was affixed 
using a custom headgear and positioned to measure blood flow velocity at the M1 segment 
(segment of MCA where blood flows horizontally) of the middle cerebral artery via the temporal 
window at a depth of 50-65mm. Data were continuously acquired at 1kHz per channel via an 
analog-to-digital converter (PowerLab/16SP ML795; ADInstruments, Colorado Springs, CO), 
recorded to LabChart (ADInstruments, Colorado Springs, CO) and stored for offline analysis 
(Figure 3.11). Data processing and analysis was performed with custom written software using 
LabView 11 (National Instruments, Austin, TX).   
 
Figure 3.11. Powerlab data acquisition. Channels recorded, from top to bottom: ECG, CO2, O2, Raw MSNA, 
Finapres BP, CBFv (right middle cerebral artery), CBFv (left middle cerebral artery), Integrated MSNA.  
 
3.2.3 Microneurography  
Postganglionic sympathetic nerve activity recordings were acquired from a muscle nerve fascicle 
in the right or left peroneal nerve, posterior to the fibular head. Nerve activity was recorded using 
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tungsten microelectrodes with a diameter of 200µm at the shaft and tapering to an uninsulated tip 
of 1 to 5µm. A reference electrode was subcutaneously inserted 1 to 3 cm from the recording 
electrode. The electrodes were connected to a preamplifier and an amplifier. The neural activity 
was amplified with a gain of 20,000 and fed through a bandpass filter with a bandwidth of 0.3-
5.0 kHz via an isolated amplifier (NeuroAmp EX, ADInstruments, Dunedin, New Zealand).  
 
Microneurographic recordings were deemed acceptable based on previous criteria [271]. First, 
the electrode in the peroneal nerve must elicit involuntary muscle contraction in response to 
weak electrical stimulation (1-3V, 0.2 msec, 1Hz). Next, stretching or tapping muscles supplied 
by the impaled nerve fascicle elicits afferent mechanoreceptor discharges and stroking the skin in 
the same region does not evoke afferent discharges. Third, spontaneous intermittent bursts occur 
synchronized to cardiac cycles. The bursts should increase in frequency and amplitude during 
phase 2 and 3 of a Valsalva maneuver [253].  
  
3.2.4 Study Design 
 
Figure 3.12. Experimental protocol timeline.  
 
All studies were performed in the Centre for Translational Physiology at the University of Otago, 
ambient temperature between 22˚C and 23˚C. Subjects were placed in the supine position, with 
the leg being targeted for MSNA supported to maintain slight knee flexion. After a 10-minute 
stabilization period, baseline data was recorded for 5 minutes (Figure 3.12). Subjects then 
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underwent pharmacological BP manipulation via the modified Oxford method and non-
pharmacologically via the rapid thigh-cuff deflation technique.  
 
3.2.5 Baroreflex Sensitivity 
Sympathetic arterial BRS was assessed through the use of both spontaneous recordings and the 
modified Oxford method as previously described in section 3.1.3.1  [98, 258, 259]. Sympathetic 
arterial BRS was calculated as the relationship between average integrated MSNA and DBP. 
DBP was used due to being more closely related to changes in MSNA than SBP [104]. MSNA 
recordings were normalized by allocating an amplitude of 1000 arbitrary units (AU) to the 
largest baseline burst and calibrating all subsequent nerve activity to the same scale. Nerve 
activity for both modified Oxford trials was pooled and averaged over 3mmHg pressure bins, 
removing any potential influence from non-baroreflex stimuli [259, 283]. Any DBP bins not 
containing cardiac cycles were excluded. The BRS slope was calculated from the relationship 
between the integrated area of each bin’s signal average and DBP. Each subject’s BRS was 
presented as the average slope of the two trials.  
 
3.2.6 Spectral and transfer function analysis. 
Transfer-function analysis of steady-state baseline data was used to quantify dynamic CA [8, 
13]. Beat-to-beat MAP and mean CBFv signals were spline interpolated and resampled at 4 Hz 
for spectral and transfer function analyses based on the Welch algorithm. Each recording was 
first subdivided into five successive windows that overlapped by 50%. Data within each window 
were linearly detrended and passed through a Hanning window before fast Fourier transform 
analysis. For transfer function analysis, the cross-spectrum between MAP and mean CBFv was 
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determined and divided by the MAP autospectrum to derive the transfer function coherence, 
gain, and phase. Individual transfer functions were calculated without attempting to unwrap the 
phase spectrum. Spontaneous MAP and mean CBFv spectral power and the mean values of 
transfer function coherence, gain, and phase were calculated in the LF and VLF ranges [8]. The 
transfer function H (f) between MAP and mean CBFv was calculated as:  
H (f) = Sxy(f)/Sxx(f) 
Sxx(f) is the autospectrum of  changes in MAP and Sxy(f) is the cross-spectrum between MAP and 
CBFv. The magnitude of transfer function H (f) and phase spectrum |ϕ (f)| were attained from the 
real HR (f) and imaginary part HI (f) of the complex transfer function:  
|H (f)| = ([ HR (f)]2 + [HI (f)]2) 
ϕ (f) = tan-1[HI (f)/ HR (f)] 
The cerebrovascular system’s linearity modeled by H (f) and the reliability of H (f) were 
evaluated through a magnitude-squared coherence (MSC) function, estimated as  
MSC (f) = |Sxy(f)|2/[ Sxx(f) Syy(f)| 
Where Syy(f) is is the autospectrum of changes CBFv. 
The relative amplitude and time relationship between MAP and mean CBFv are reflected as 
transfer gain and phase shifts over a specific frequency range. The spectral power of MAP and 
mean CBFv, mean transfer function gain , phase and coherence function between MAP and 
mean CBFv were calculated in very-low (0.02-0.07Hz), low- (0.07-0.20Hz, and high-frequency 
(0.20-0.30Hz) ranges. The low-frequency range is used particularly as it is the only frequency 
range not associated with fluctuations caused by respiratory frequency and has been shown to 
most precisely define changes caused by autoregulatory mechanisms [8, 282]. In this range, 
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impairment of CA is represented by an elevation of transfer function gain and/or a decrease in 
phase [7]. 
 
3.2.7 Tiecks Autoregulatory Index 
Tiecks ARI [159] was also used to separately quantify dynamic CA on a graded scale from 0 to 
9, with 0 representing no cerebral buffering capacity and 9 representing a strong cerebral 
buffering capacity. The quantifications of CA in this paper are representative of both the 
mechanical and active regulatory processes buffering CBF [275].  
 
3.2.8 Blood Pressure Variability 
BPV was defined as the SDs of averaged beat-to-beat SBP, MAP and DBP during the 5-minute 
supine baseline recording. The variation coefficients were also derived as the SD, divided by the 
mean and multiplied by 100.  
 
3.2.9 Statistics 
Relationships between variables were described using Pearson’s product moment correlation 
coefficients and least squares regression. Values were expressed as mean+/-SD unless otherwise 
stated. Statistical significance was defined a priori at p<0.05. All relationships in the results are 
described using R. R is an indicator of the strength of the relationship between two variables and 
ranges from -1 to 1, with a value of 0 indicating that there is no correlation between the two 
variables and -1 or 1 representing a strong negative or positive correlation, respectively. All data 
were analyzed using SPSS v22 (SPSS, Chicago, IL).  
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Chapter 4. Results 
4.1 Baseline 
Of the 14 male subjects that participated, nerve recordings were successfully obtained from 11 
subjects based on the criteria listed in section 3.1.5. The mean ± SD physiological data is 
presented in Table 4.1, including resting MSNA in both microvolts and Normalized units.  
Variable Mean ± SD 
Age, yr 24 ± 2.83 
Weight, kg 88.56 ± 10.99 
Height, m 1.8 ± 0.059 
Body mass index, kg/m2 27.3 ± 4.02 
Resting heart rate, beats/min 59.96 ± 15.14 
Systolic Blood Pressure, mmHg 139.57 ± 16.92 
Diastolic Blood Pressure, mmHg 67.78 ± 17.06 
Mean Arterial Pressure, mmHg 87.38 ± 16.95 
ETCO2, mmHg 40.81 ± 2.24 
Respiratory Rate, breaths/min 18 ± 2.57 
Resting muscle sympathetic nerve activity     
Bursts/min 22.25 ± 8.29 
Bursts/100 heartbeats 38.62 ± 18.13 
Burst latency, s 1.35 ± 0.08 
Table 4.1. Subject Baseline Characteristics. Values are reported as mean ± SD 
4.2 Sympathetic Arterial BRS and CA 
Figure 4.1 demonstrates the relationship between sympathetic arterial BRS quantified at rest and 
during the modified Oxford protocol and CA as quantified through spontaneous TFA normalized 
gain and ARI derived from bilateral thigh cuff deflation. Arterial BRS was inversely related to 
CA but the relationship appears to be metric dependent. TFA nGain was positively correlated to 
spontaneous BRS (R = -0.74, P = 0.009) but not modified Oxford BRS (R = -0.1, P = 0.76). An 
R of -0.74 suggests that the linear regression is a relatively good fit and a P value less than 0.01 
suggests that TFA nGain and spontaneous BRS are strongly correlated to one another. The R of  
-0.1 observed between TFA nGain and modified Oxford BRS demonstrates a very poor linear 
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regression fit and a P value of 0.76 indicates that the two parameters are very likely not 
correlated to one another.  
        
Figure 4.1. Relationship between arterial baroreflex sensitivity as assessed by the modified Oxford method and 
spontaneously and cerebral autoregulation as assessed by Tiecks’ Autoregulatory Index and transfer function 
analysis gain. (LF = low frequency, nGain = normalized gain). Each point represents data for a given individual.  
 
ARI was inversely correlated to modified Oxford BRS (R = 0.64, P = 0.03) but not spontaneous 
BRS (R = 0.37, P = 0.26). An R of 0.64 suggests that the linear regression observed between 
ARI and modified Oxford BRS is a good fit and a P value less than 0.05 suggests that ARI and 
modified Oxford BRS are correlated to one another. An R of 0.37 suggests that the linear 
regression observed between ARI and spontaneous BRS is not a strong fit and an insignificant P 
value of 0.26 suggests that the two variables may not be correlated to one another  All plots 
passed the Shapiro-Wilk normality test and did not require transformation.  
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4.3 Resting MSNA and CA 
Figure 4.2 demonstrates that though not significant, resting MSNA quantified as mean integrated 
activity/100 heartbeats demonstrated an inverse relationship trending towards significance with 
both ARI (R = -0.44, P = 0.17) and TFA gain (R = 0.57, P = 0.063). Both plots passed the 
Shapiro-Wilk normality test and did not require further transformation. 
 
Figure 4.2. Relationship between spontaneous MSNA activity (integrated activity/100 heartbeats) and cerebral 
autoregulation quantified through ARI and TFA LF nGain. Each point represents a given individual.  
 
Figure 4.3 demonstrates that when resting MSNA was quantified as burst incidence, the 
relationship between resting MSNA and CA was less significant. MSNA burst incidence still 
demonstrated an inverse relationship trending to a lesser degree to significance with both ARI (R 
= -0.33, P = 0.33) and TFA gain (R = 0.53, P = 0.10). The lower R of these two regressions 
suggests that quantifying MSNA as bursts is less accurate than accounting for integrated burst 
area. Both plots passed the Shapiro-Wilk normality test and did not require further 
transformation. 
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Figure 4.3. Relationship between burst incidence (Bursts/100 heartbeats) and cerebral autoregulation quantified 
through ARI and TFA LF nGain. Each point represents a given individual.  
 
4.4 Blood Pressure Variability 
Tables 4.2 and 4.3 summarize the relationship between CA and BRS to indexes of BPV. BPV 
and BP variation coefficients were not related to modified Oxford BRS or ARI but most were 
significantly correlated to spontaneous BRS and TFA LF gain.  These results demonstrate an 
inverse relationship between BPV and spontaneous BRS and a positive relationship between 
BPV and TFA gain. Because a greater BRS is represented by a greater negative value, the 
significant positive R values of the relationship between BPV and BRS are representative of an 
inverse relationship, meaning that a greater BRS is associated with a lower BPV. Because a 
smaller TFA gain is associated with a greater CA, the significant negative R values of the 
relationship between BPV and TFA gain demonstrate a positive relationship between BPV and 
CA. These results are consistent with previous results observing the relationship between BPV 








Variable R P R P 
SD SBP, mmHg -0.20 0.56 0.33 0.32 
SD MAP, mmHg -0.14 0.69 0.60 0.052 
SD DBP, mmHg -0.09 0.78 0.62 0.041 
COV SBP, % 0.0013 1.0 0.49 0.12 
COV MAP, % 0.20 0.56 0.76 0.006 
COV DBP, % 0.22 0.52 0.73 0.01 
Table 4.2. Relationships between sympathetic arterial BRS and BPV. SD SBP, systolic blood pressure standard 
deviation; SD MAP, mean arterial pressure standard deviation; SD DBP, diastolic blood pressure standard deviation; 
SD DBP, diastolic blood pressure standard deviation; COV SBP, systolic blood pressure coefficient of variation; 








ARI TFA gain 
Variable R P R P 
SD SBP, mmHg -0.03 0.93 -0.54 0.09 
SD MAP, mmHg -0.20 0.55 -0.68 0.02 
SD DBP, mmHg -0.19 0.57 -0.72 0.01 
COV SBP, % 0.0094 0.98 -0.70 0.017 
COV MAP, % -0.010 0.98 -0.80 0.0032 
COV DBP, % 0.018 0.96 -0.79 0.0036 
Table 4.3. Relationships between cerebral buffering capacity and BPV. SD SBP, systolic blood pressure standard 
deviation; SD MAP, mean arterial pressure standard deviation; SD DBP, diastolic blood pressure standard deviation; 
SD DBP, diastolic blood pressure standard deviation; COV SBP, systolic blood pressure coefficient of variation; 






Chapter 5. Discussion 
5.1 Main Findings 
This study is the first to examine the interindividual relationships between sympathetic arterial 
baroreflex and CA in healthy human subjects. Consistent with our hypothesis we found that CA, 
as assessed by LF transfer function gain and ARI, is inversely related to spontaneous and 
pharmacological indexes of sympathetic arterial BRS, respectively. Additionally, we observed a 
significant inverse relationship between some measure of BPV and BRS and a positive 
relationship between some metrics of BPV and CA. Collectively, these data indicate that 
individuals with an attenuated BRS tend to have a greater CA (and vice versa), which suggests 
that among young normotensive men, a reciprocal balance between sympathetic arterial 
baroreflex function and CA is important in regulating stable cerebral perfusion. 
 
5.2 Interactions between Baroreflex and CA 
The traditional concept of CA proposed by Lassen et al. suggests that CBF plateaus at a near 
constant value over a broad range of arterial blood pressure levels (60-150 mmHg) [19]. 
According to this construct, baroreflex regulation of BP plays a role in CBF control only in so far 
as ensuring that BP is maintained within the effective ‘autoregulatory range’.  However, 
Lassen’s concept of CA were based on point estimates of blood pressure and CBF and therefore 
do not fully describe the dynamic relationships between blood pressure and CBF over a broad 
range of physiologically relevant timescales.  The advent of high temporal resolution TCD has 
shown that CA is a frequency-dependent process that achieves relative (not absolute) buffering 
of CBF against dynamic BP perturbations. Therefore, both baroreflex control of blood pressure 
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and autoregulation of cerebrovascular resistance contributes to CBF regulation although 
precisely how these two processes relate to each other is not well understood. 
 
In theory at least three potential relationships are possible.  First, there may be no relationship 
since CA is mediated by a multitude of mechanisms including myogenic and metabolic 
processes that can occur independently of cerebral sympathetic drive.  Second is that individuals 
with high sympathetic BRS might also be expected to have better CA.  This is plausible given 
that the sympathetic nervous system regulates both systemic vascular resistance as well as 
regional cerebrovascular resistance.  Finally, it is possible that individuals with high sympathetic 
BRS might have lower CA since there might be less blood pressure instability for the cerebral 
circulation to contend with. The inverse relationship between BPV and BRS and positive 
relationship between BPV and CA demonstrated in this study and previously by Tzeng et al. [13] 
supports this last possibility.  
 
5.3 Sympathetic Arterial BRS vs CA 
To address this gap in our current knowledge, this study quantified the relationships between 
sympathetic BRS and CA. Our analyses showed that significant relationships were observed 
between spontaneous BRS and TFA LF nGain (R = -0.74, P = 0.009) and modified Oxford BRS 
and ARI (R = 0.64, P = 0.03). There was no correlation between spontaneous BRS and ARI (R = 
0.37, P = 0.26) or modified Oxford BRS and TFA nGain (R = -0.1, P = 0.76), although its likely 
that the lack of a correlation may be related to the metrics used. Both TFA nGain and 
spontaneous BRS are derived from spontaneous baseline data and ARI and modified Oxford 
BRS are both representative of a response to a driven change in BP.  Thus, it appears that our 
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results were significant when metrics of BRS and CA quantification were derived from a similar 
BP input.  
 
Because the sympathetic arterial arm of the baroreflex plays a large role in blood pressure 
regulation [217, 218] and cardiac BRS and sympathetic BRS are not correlated [15], an 
understanding of the sympathetic arterial BRS relationship to CA is critical to understanding the 
relationship between the baroreflex and CA. This study demonstrates an inverse relationship 
between the two mechanisms, [13, 14] and therefore suggests that the integration between CA 




Accounting for the potential interaction between the baroreflex and CA may lead to better 
understanding of organ perfusion maintenance in clinical conditions such as orthostatic 
intolerance, hypovolemia and VVS. Currently, attempts at uncovering predictive models for 
these clinical conditions only incorporate the baroreflex or CA individually. However, 
quantifying an individual’s ability to maintain CBF in a clinical condition through BRS alone 
does not account for the potential role of CA (and vise versa). Our results suggest that 
individuals with a diminished BRS are not necessarily at risk of presenting a diminished CBF 
due to having a greater CA. Differences in CA may explain why sympathetic arterial BRS is the 
same in subjects having high or low tolerance to hypovolemia [123] or also why predictive BRS 
models on VVS remain inconclusive, with studies demonstrating both decreased [143, 146, 147] 
or increased [148, 149, 151] BRS. Similarly, including information on the baroreflex may 
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provide needed detail to clinical studies focusing on CA. Incorporating the multiple regulatory 
reflex systems involved may lead to improved predictive models for clinical conditions affecting 
CBF.   
 
The relationship demonstrated between CA and the baroreflex may lead to better definitions of 
normal regulatory control of CBF.  To date, there are no explicit definitions of normal CA or 
BRS values. When observed individually, an attenuated BRS or CA is traditionally thought of as 
insufficient but our study indicates that otherwise normal healthy individuals with an attenuated 
BRS have a high CA (and vise versa). This suggests an attenuated BRS or CA individually may 
not necessarily be indicative of an inability to maintain CBF in the face of acute BP 
perturbations. Therefore, an accurate assessment of an individual’s ability to maintain CBF may 
require the quantification of both BRS and CA. 
 
The potential compensatory interactions demonstrated between the baroreflex and CA supports 
the concept of the “cross-talk” hypothesis originally proposed by Sykora et al. [284] along with 
the finding that BRS may act as an independent clinical predictor of stroke outcome. This 
hypothesis proposes that neural communication exists between the baroreflex and CA and that 
the two mechanisms may both be part of the same underlying regulatory continuum. Under this 
concept, dynamic CA may adjust over time depending on the capability of BRS to optimize CBF 
or vise versa [285]. This may explain why hypertensive individuals with an impaired baroreflex 
have greater dynamic CA than normotensive control subjects [286]. Conversely, patients with an 
impaired dynamic CA as result of excessive intracranial pressure demonstrate baroreflex 
hypersensitivity, which may be targeted at restoring normal CBF [287]. Our results support the 
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cross-linked hypothesis, demonstrating that BPV is inversely related to BRS and positively 
related to CA. The potential mechanism controlling the balance between the baroreflex and CA 
may therefore be an important target for therapeutic intervention in stroke treatment or 
prevention.  
 
Finally, the results of this study add further evidence to the growing body of literature 
demonstrating a balance between the various features of the cardiovascular system. Previous 
studies have established a relationship between CO and MSNA. In healthy normotensive young 
subjects, the two are inversely related, such that individuals having a high resting CO tend to 
have a low resting MSNA and vice versa [114]. Being that MAP is a product of CO and TPR and 
MSNA is representative of TPR [114], it is logical that MSNA and CO are inversely related to 
one another. This may explain why baseline MSNA is not directly related to BP [104] and may 
in part explain the diversity seen in both CO and MSNA in healthy normotensive individuals 
[113]. Our results suggest that a similar balance exists between CA and the baroreflex. Much like 
CO and MSNA balancing one another to provide an optimal MAP, CA and the baroreflex may 
balance one another to provide a optimal CBF regulation. Individually, both CA and the 
baroreflex are vital components to providing end organ perfusion. Like CO and TPR, CA and the 
baroreflex are highly variable in a population of healthy subjects. Given that CBF is a dictated by 
systemic BP and local vascular resistance, the interaction of both variables may be a better 





5.5 Potential explanations  
Physiological diversity is a ubiquitous feature of living systems that underpins many phenotypic 
patterns of adaptation and disease. However, the origins of such diversity are poorly understood 
with functional variations often dismissed as random measurement noise.  Our findings suggest 
this view is overly simplistic since the inter-individual variance in some functional parameters, 
such as sympathetic BRS and CA, appear to be underlain by regulatory structure and 
organisation.  It is important to emphasise that correlations do not imply causation and therefore 
it not possible for us to pinpoint precisely how or why these relationships exists. However, we 
speculate that consideration of dynamical systems theory and its intersection with evolutionary 
theory may give insight into the possible origins of these relationships.   
 
From a dynamic systems theory perspective, physiological mechanisms such as the baroreflex 
and CA are highly complex systems that involve a multitude of components from genes to 
molecules and cells and higher order assemblies [288, 289].  In theory, the constituent 
components can be  combined in enumerable ways yet in reality the configuration, 
dimensionality and complexity of physiological systems can be reduced to certain preferred 
states of co-ordination or ‘attractor’ states [289, 290].  The defining feature of an attractor state is 
that system dynamics are ordered, stable, and optimally configured to support the functions of 
the system [288].  Thus, the apparent ‘functional equilibria’ that exists between sympathetic BRS 
and CA could reflect, at least in part, the nature of attractor states that defines how the systems 
optimally converge to regulate CBF among young healthy males.  However, it must be 
acknowledged that time is an important dimension in dynamic systems theory and in this study 
measurements were made only at a single timepoint. Therefore, it is possible that differentiation 
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of attractor states could alter these relationships as people age and continue to physiologically 
interact with the environment.   
 
Another intriguing dimension to these concepts is that the precise nature of dynamic systems 
may have evolutionary origins and implications.  One of the central tenants of the modern 
evolutionary synthesis is that natural selection acts on genes or individuals.  Physiological 
function is generally not considered important except in constraining the fitness of individual 
organisms in terms of its reproductive success after genetic mutations have created the 
possibility of an advantage [291, 292].  However, attempts to better understand the genotype-
phenotype relationship has led to the idea that functional systems may themselves be a target of 
selection.  According to this revised framework, physiological systems and the functions they 
serve may have arisen because they confer a survival advantage. Thus populations composed of 
individuals that employ diverse functional strategies to maintain homeostasis may result in more 
resilient populations (by avoiding similar functional vulnerabilities) to stressors such central 
hypovolemia (e.g. secondary to shock and dehydration). 
 
5.6 Methodological Considerations 
The results of this study must be interpreted in the context of several methodological 
considerations. This study focuses primarily on young healthy males and the findings from this 
study can therefore only be generalized to this population. Recent studies have demonstrated age 
and gender related variances in MSNA neural transduction [112, 293]. Variances in neural 
transduction would alter observed BRS and may affect the relationship between the baroreflex 
and CA. Further investigation is warranted on the relationship between the baroreflex and CA in 
female and older male populations. The correlations in this study varied depending on the 
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method of quantifying cerebral buffering capacity. We have previously demonstrated a lack of 
convergent validity between quantification methods of cerebral buffering capacity [215] and the 
physiological interpretation of each method’s results warrants further research. While there is a 
lack of convergence between CA quantification methods, our results derived from Tiecks ARI 
and TFA gain both support the concept of an inverse relationship between CA and the 
baroreflex. The following section discusses these methodological considerations in greater detail. 
 
5.6.1 Velocity vs. flow  
In this study, we use CBFv measurement as a surrogate of CBF. The use of TCD derived 
measurements of CBFv as a representative of CBF is dependent on the assumption that MCA 
diameter stays constant. Due to the quadratic influence of vessel cross sectional area on diameter, 
and consequently flow, minor changes in vessel constriction would result in substantial 
disparities between change in MCAv and CBF. However, previous studies have demonstrated no 
change in MCA diameter in resting and lower body negative pressure conditions[234]. With a 
constant MCA diameter, we can assume that changes in CBFv accurately represent changes in 
CBF and is therefore an acceptable surrogate measurement.  
 
5.6.2 Assessment of Cerebral Autoregulation  
For this study, we assessed CA through both TFA of spontaneous fluctuations in MAP and CBFv 
at baseline and Tieaks ARI during thigh cuff deflation. A drawback to both of these techniques is 
that they both assume linearity between BP and CBF and do not account for the nonlinear 
properties associated with CA [215, 294, 295]. Additionally, we have previously demonstrated a 
lack of convergence between CA quantification methods [215]. Due to their lack of convergence, 
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the variation seen between analysis employing ARI and TFA gain in this study was not a 
surprise. Because of the potential variance between CA quantification techniques, their 
inconsistencies must be taken into consideration prior to making any physiological 
interpretations.  However, our results demonstrate a similar relationship between CA and 
sympathetic arterial BRS regardless of which CA quantification technique used and are therefore 
acceptable for the purpose of this experiment. As there is no gold standard method for 
quantifying cerebral buffering capacity, these two commonly used indexes provide as good of a 
depiction as currently is possible.   
 
5.6.3 Assessment of Sympathetic Arterial BRS  
Currently there is no gold standard technique for the quantification of BRS. While assessment of 
BRS under spontaneous resting conditions is common, external influences on nerve activity 
cannot be ruled out and only a narrow range of associated BP values are represented. 
Pharmacological BP manipulations may have unknown external effects on the baroreflex but the 
use of vasoactive drugs allows the quantification of nerve activity responding to all BP values 
ranging from hypo- to hypertensive. This results in a slope derived from a greater number of 
points making it a more robust assessment of BRS. By quantifying BRS through both techniques 
in study, we are able rule out the possibility of the relationship between BRS and CA being 
dependent on the BRS quantification metric used.   
	
In this study, MSNA is used with the assumption that it plays a direct role in regulating 
peripheral arterial resistance. MSNA is not a direct measure of peripheral resistance in itself but 
is positively related to TPR in young males [114].  However, the relationship between MSNA 
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and TPR may be altered or nonexistent in older male, young female and older female populations 
[112, 293, 296, 297]. Therefore, the effects of age and gender need to be considered before 
assuming these results provide a collective representation for all humans. 
 
5.6.4 Age and Gender Differences in Baroreflex Sensitivity 
This study was conducted on young healthy males and the results are not necessarily 
representative of other age groups or females. The previous studies on the relationship between 
cardiac BRS and CA pool both male and female subjects [13, 14]. Additionally, the study by 
Tzeng et al. [13] was on young subjects (mean age, 24 years) while the study by Nasr et al. [14] 
was on slightly older healthy subjects (median age, 38 years) and older carotid stint patients 
(median age, 68 years). This suggests that the results of this study could be similar if tested in 
older or female populations. However, the differences in MSNA transduction with age and 
gender may alter the balance between sympathetic arterial BRS and CA. Therefore, further 
research should be conducted on the effects of age and gender.  
 
Prior studies have demonstrated alterations in neural transduction and BRS in older populations 
and aging is associated with alterations in BP control and responsiveness to vasoactive drugs 
[298-302]. Hart et al. [112] demonstrate that resting MSNA activity increases with age. Yet 
despite the greater nerve activity, older males exhibit no correlation between MSNA and TPR 
suggesting that the ability of efferent nerve impulses to elicit arterial vasoconstriction is 
decreased [112]. Other studies have demonstrated that α-Adrenergic responsiveness to 
vasoconstrictor drugs, such as phenylephrine or tyramine, is significantly decreased in healthy 
older men [301, 303]. The decrease in neural transduction associated with aging may alter the 
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relationship between BRS and CA. Therefore, we cannot say whether the results of this study 
pertain to older males. Without a balance between the two mechanisms, it is possible that the 
prevalence of end organ cardiovascular disease such as stroke is greater in older populations.  
 
A similar disconnect between MSNA and TPR is observed in female subjects. Unlike young 
males, TPR is unrelated to MSNA in young females [293]. Even when TPR is normalized for 
body surface area, the positive relationship is still maintained in male subjects and nonexistent in 
female subjects. This may relate to the blunted vasoconstrictor response to α-Adrenergic 
stimulation [304] and suggests that the sympathetic arterial baroreflex may not play as 
significant role in BP regulation in young females. Hart et al. [293] also demonstrate that unlike 
males, there is no correlation between MSNA and CO in female subjects, even when CO is 
normalized to body surface area. This may be attributed to the effects of sex hormones such as 
estrogen. Estrogen is a vasodilator [305] and is also suggested to increase the bioavailability of 
NO [306]. The vasodilatory properties of estrogen and NO may override α-mediated 
vasoconstrictive signals sent via MSNA. These factors were not considered in the current study 





In summary, metrics of CA were inversely related to sympathetic arterial BRS as quantified 
using the modified Oxford method and at spontaneous baseline. The three major conclusions we 
can draw from these findings are: 1) that reciprocal relationships between redundant 
physiological mechanisms may be a fundamental feature of complex systems that need to co-
ordinate to achieve an integrative function, 2) that the diversity underpinning the functional 
processes associated with CBF regulation are non-random but underlain by structure and 
organization, and 3) that it may be conceptually misleading to assign ‘normal values’ to 
physiological functions that operate as part of a more complex networks of systems.   
 
The completion of the research in this thesis has opened up several new areas worthy of further 
investigation. First, the relationship demonstrated between CA and the baroreflex leads to the 
possibility of developing a better understanding of functional diversity and the broad 
implications it may provide in explaining interindividual differences in physiological stability, 
resilience and performance. But in order to do so, future studies should further explore the 
relationship between the two mechanisms.  
Second, future studies on the relationship between sympathetic arterial BRS and CA should 
focus on age and gender effects. Our subject population consisted solely of healthy young males 
and our results therefore do not necessarily represent relationships seen in females or other age 
groups. As previously discussed (see section 5.6.4), age [112] and gender [293] affect the 
baroreflex and may alter the relationship between BRS and CA. Several studies have 
demonstrated that BRS diminishes with age and may be modified by female sex hormones. 
Demonstrating the relationship between BRS and CA in pediatric, young and old male and 
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female populations is necessary to determine whether this relationship is present in all 
populations.  
Finally, future studies should also provide greater detail on the individual components 
underlying BRS or CA and their potential roles in the relationship between the two. Variation of 
the mechanical and neural components of the sympathetic arterial baroreflex may provide greater 
information on baroreflex interactions with CA. The quantification of mechanical and neural 
components through duplex Doppler ultrasound measurement of common carotid artery diameter 
changes is well established for the cardiac baroreflex [95, 96] and the principle of splitting the 
integrated BRS up into separate mechanical and neural components is the same for the 
sympathetic arterial baroreflex. Further, providing details on the role of neural transduction from 
sympathetic nerve activity to TPR may provide an added level of detail. Previous studies have 
suggested that transduction from MSNA to TPR may differ by race [307] or gender [293]. 
Adding greater detail on the underlying steps of the observed mechanisms may lead to a better 
explanation of variations between BRS and CA.  
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